Development of a Microarray Biosensor for Real-Time and Continuous Measurement of Neurochemicals by Hossain, Md Imran
Louisiana Tech University 
Louisiana Tech Digital Commons 
Doctoral Dissertations Graduate School 
Summer 8-2020 
Development of a Microarray Biosensor for Real-Time and 
Continuous Measurement of Neurochemicals 
Md Imran Hossain 
Follow this and additional works at: https://digitalcommons.latech.edu/dissertations 
   
 
DEVELOPMENT OF A MICROARRAY BIOSENSOR FOR 
REAL-TIME AND CONTINUOUS MEASUREMENT 
OF NEUROCHEMICALS 
by 












A Dissertation Presented in Partial Fulfillment 
of the Requirements of the Degree 









COLLEGE OF ENGINEERING AND SCIENCE   





Continuous simultaneous measurement of glutamate (GLU), an excitatory 
neurochemical, and γ-aminobutyric acid (GABA), an inhibitory neurochemical, 
constitutes one of the major challenges in neuroscientific research. Maintaining 
appropriate levels of GLU and GABA is important for normal brain functions. Abnormal 
levels of GLU and GABA are responsible for various brain dysfunctions, like epilepsy 
and traumatic brain injury. GLU and GABA being non-electroactive are challenging to 
detect in real-time. To date, GABA is detected mainly via microdialysis with a high-
performance liquid chromatography (HPLC) system that employs electrochemical (EC) 
and spectroscopic methodologies. However, these systems are bulky and unsuitable for 
real-time continuous monitoring. As opposed to microdialysis, biosensors are easy to 
miniaturize and are highly suitable for in-vivo studies. Unfortunately, this method 
requires a rather cumbersome process that relies on externally applied pre-reactors and 
reagents. Here, we report the design and implementation of a GABA microarray probe 
that operates on a newly conceived principle. It consists of two microbiosensors, one for 
GLU and one for GABA detection, modified with glutamate oxidase and GABASE 
enzymes, respectively. The detection of GABA by this probe is based upon the in-situ 
generation of α-ketoglutarate from the GLU oxidation that takes place at both 
microbiosensor sites. By simultaneously measuring and subtracting the H2O2 oxidation 
currents of GLU microbiosensor from GABA microbiosensor, GABA and GLU can be 
iv 
detected continuously in real-time in vitro and ex vivo. This mechanism happens without 
the addition of any externally applied reagents. We optimized our novel approach in 
commercially available ceramic-based probes. The GABA probe was successfully tested 
in an adult rat brain slice preparation. However, those electrodes are geometrically 
limited (we cannot have a sentinel site at the same spatial level as GLU and GABA sites). 
Keeping theseissues in mind, we have developed a microwire array sensor that is not only 
capable of simultaneous measurement of GLU and GABA, but is also able to track signal 
resulting from interferents (e.g. Ascorbic Acid, AA). The unique geometry enables these 
microwire probes to measure GLU, GABA and interferents in the same spatial level.  A 
Simple fabrication procedure and easy integration with the existing amperometric 
systems allow us to use them in cell culture, brain tissue, and in vivo recordings as an 
inexpensive alternative to our planar electrodes. We demonstrated the effectiveness of the 
probes in rat brain tissue. We were able to get. Additionally, we determined the 
excitation/inhibition (E/I) ratios for different stimulations which have clinical relevance. 
Our results about this E/I balance can help refine electrical stimulation parameter for 
different clinical purposes (e.g. deep brain stimulation). Finally, we successfully tested 
our probe in awake-free behaving rats. In summary, our results suggest that microwire 
probes have the potential to become a powerful tool for measuring GLU and GABA in 
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1.1 Problem Statement 
The brain is the most complex organ in the human body. It has hundreds of 
billions of neurons and they are connected through an intricate network of synapses. 
Because of the central role it plays in vital electrophysical functions, the brain has been at 
the center of research for over a century.  Yet the inherent multifaceted nature of the 
brain’s physiology and the complex nature of the brain pathology addressed further 
research needs in this field. The brain interconnects various organs with electrical pulses, 
neurochemical transportation, stimulation receptors etc. If these connections are disturbed 
in any way, various neurological disorders occur. Diseases like Alzheimer’s disease, 
Parkinson’s disease, and epilepsy are direct consequences of neurochemical imbalance in 
the brain [1].  
The detection of various neurochemicals with sufficient resolution, sensitivity and 
selectivity is essential for understanding the complex interplay of neurons and chemicals. 
Although various methods are available for the detection of these neurochemicals, often 
times they are limited by spatio-temporal resolutions, introduction of external reagents 
etc. Therefore, a self-sufficient sensor that can continuously detect neurochemicals with 
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high spatio-temporal resolution without the addition of any external reagents is a highly 
desirable tool to strengthen current investigation efforts. In this work we add to the 
existing body work [2]–[4] on the development of multiplexed neural probes for real-time 
sensing of neurochemicals. 
1.2 Research Motivation 
Glutamate (GLU) is the main excitatory neuron of the brain and γ-aminobutyric 
acid (GABA) is the main inhibitory neuron of the brain. This seemingly opposite 
characteristic of these neurochemical maintains a healthy balance in the brain. The 
imbalance of these neurochemicals results in abnormal signaling. This is an underlying 
signature of brain dynamical disorders such as epilepsy, Parkinson’s disease and 
Alzheimer’s disease, traumatic brain injury, and drug addiction [2], [5]–[8]. This critical 
research need to monitor the long-term spatio-temporal dynamics of GLU and GABA in 
the brain served as the main motivational factor of our research. 
The current gold standard for neurochemical detection is based on microdialysis. 
However, microdialysis sampling takes in the range of minutes whereas vesicular event 
happens in the seconds range. Additionally, microdialysis needs to be integrated with 
microfluidic set up [9], chromatography which requires an additional bulky setup. Other 
spectroscopic or optical methods are limited by low temporal resolution and 
unavailability of reporter molecule (e.g. fluorescence dye). In recent decades 
electrochemical sensors have risen as a strong contender for real-time, continuous 
detection of neurochemicals [3], [10]. GLU and GABA being non-electroactive are 
challenging to detect directly on the sensor surface. Therefore, researchers generally use 
an enzyme modified surface for GLU or GABA detection [11], [12]. Still, several 
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limitations of these sensors remain. Surface fouling and the need to add an external 
reagent for sensing GABA limit in-vivo real time application [11], [13]. A sensor that 
does is self-contained (does not need external reagent) and usable long-term without 
fouling is a desirable tool for investigators worldwide. Additionally, microarray using 
different platforms (e.g., wires) needs to be investigated to find an inexpensive and more 
versatile alternative to present methods. 
1.3 Research Objectives 
The main objective of this dissertation is to develop a robust microsensor that can 
simultaneously detect GLU and GABA in real-time. We added to existing literature of 
GLU-GABA microsensor with various surface modifications[14]. To overcome the 
limitations of commercially available electrodes, we also fabricated an in-house custom-
made probe using microwires that can offer the same functionalities at a lower cost. 
Overall, we want to accomplish the following three objectives. 
1) Development and optimization of commercial (8-TRK) probe for simultaneous 
measurement of GLU and GABA: We will modify the commercially available 8-TRK 
(Cenmet, Lexington, KY, USA) for high sensitivity, high selectivity, lower limit of 
detection (LOD) and longer linear range without addition of any external reagents. We 
calibrate GABA in presence of both α-ketoglutarate and glutamate solution. Additionally, 
we optimize for different modification parameters for enzyme coating and experimental 
conditions. We change parameters like: enzyme concentration, enzyme thickness 
(number of drops) and pH conditions. Interferent rejection layer (mPD-layer) coating 
parameters e.g scan rate, were also a research objective. Finally, a new quantification 
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procedure of GABA and GLU concentration from pre-experiment calibration is also 
needed. 
2) Fabrication and characterization of wire-based sensor for GABA and GLU 
measurement:  We will fabricate a low-cost alternative to our commercial probes that 
works on the same working principle and has similar dimensions. In the 8-TRK probes 
the eight electrodes are arranged vertically within 8mm in a ceramic-based shank.  
Because of these dimensions we cannot use all eight electrodes in a tissue slice 
experiments (slice depth ~400μm). They are unsuitable in live animal recording too as we 
can’t implant them too deep inside the brain. Other important consideration is that, in 
commercial probe the electrodes are always need to be used in pairs. This makes it 
impossible to have a blank electrode to record environmental noise along with GABA 
and GLU electrode. Our wire-based electrodes need be modified to have that 
functionality. We will call this “sentinel channel”. We will fabricate these platinum 
microwire channels and modify them for our ex-vivo and in-vivo application. 
Characterization of these wires was also an important objective. 
3) Validation of microelectrode biosensors in rat tissue slice and the brain of 
freely-moving rats: We need to validate our probes, both 8-TRK and microwire arrays, 
ex-vivo and in-vivo. Very few sensors to date have been able to successfully demonstrate 
simultaneous detection of GABA and GLU [11], [14], [15]. We need to be able to 
calculate the real-time concentration of GLU and GABA in different electrical 
stimulation conditions in brain tissue. Investigation of excitation (E, GLU concentration) 
and inhibition (I, GABA concentration) ratio is also critical. Finally; we have to 
demonstrate the suitability of our microarray channels in awake-free moving rat. We 
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need to determine the basal level of GLU and GABA as well as capture the sub-second 
fluctuations in the concentrations. 
1.4 Dissertation Format 
This dissertation is divided into seven chapters including introduction and the 
conclusion. Chapter-2 provides the background information about the methods available 
for neurochemical detection and overview of microelectrodes for neurochemical 
detection in the literature. It also introduces our novel method for GLU and GABA 
detection. We discuss our material and methods in Chapter-3. In that chapter we discuss 
biosensor preparation method, in-vivo and ex-vivo experimental method, data acquisition, 
data analysis and statistical methods. 
Chapter-4 discusses GLU-GABA probe development. We tune different 
parameters to maximize GLU and GABA sensitivity. Thorough our experiments we 
optimized, α-ketoglutarate concentration, enzyme concentration, enzyme thickness, pH 
solution and permselective interference rejection layer. Linear range for GABA was also 
discussed. Our novel GABA and GLU concentration calculation procedure was also 
introduced. Chapter-5 discusses an alternate GLU-GABA probe based on microwire 
array. Wire selection procedure and calibration of GABA and GLU is discussed. Chapter-
6 describes the validation of our probes in mostly ex-vivo environments and in-vivo 
conditions. Demonstration of real-time GABA and GLU concentration, peak parameters 
like rise time, delay time and full duration half maximum (FDHM) is also discussed. 
Dynamic features like excitation-inhibition (E/I) ratio for different electrical stimulation 
are one of highlights of this chapter. Finally, in Chapter-7 we draw conclusions fromour 






BACKGROUND AND THEORY 
 
2.1 Importance of L-Glutamate (GLU) and γ-Aminobutyric Acid (GABA) 
GLU is the main excitatory neurochemical and GABA is the major inhibitory 
neurochemical in the central nervous system (CNS). Both GLU and GABA serve 
multiple functions in the central nerves system (CNS). Both of them are important for 
normal brain functions. GLU plays important roles in depolarizing postsynaptic 
receptors, detoxification of ammonia, memory and cognitive process. γ-Aminobuteric 
Acid (GABA) is one of the most important major inhibitor neurochemical that is essential 
for normal brain function, neuronal activity, information processing and plasticity, and 
for network synchronization [16]–[18]. GABA plays a critical role in several psychiatric 
and neurological disorders, inflammation, and immune cell function and therefore, has 
been a main target of a wide range of drug therapies [16], [19]–[21].  
As a neurotransmitter GLU is produced and released glutamatergic neurons. GLU 
is transported into vesicle by vesicular glutamate transporters (vGluTs). Upon 
depolarization of the cell membrane due to electrochemical gradient, the vesicles fuse 
and release the neurotransmitter into the synaptic cleft [22]. Once in synaptic cleft, GLU 
can be transported further with the receptors such as N-methyl-D-aspartate (NMDA), α-
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amino-3-hydroxy-5-methyl-4-isoazolepropionic acid (AMPA), and 2-carboxy-3-
carboxymethyl-4-isopropenylpyrrolidine (Kainate; KA) [23]. Upon GLU binding to these 
receptors, sodium/calcium dependent transporter located in both glial cells and astrocytes, 
depolarizes the post-synaptic neurons [23].  At this final stage GLU is taken up by both 
glial cells and astrocytes [23]. This Na+ and Ca2+ dependent depolarization is responsible 
for a lot of cognitive functions [23]. However, excessive depolarization and/or GLU 
release gives rise to phenomenon of excitotoxicity [24]. In this process, GLU and other 
amino acids rapidly kill CNS neurons [24].  
In addition, GLU can also act as a precursor to GABA. In presence of glutamate 
decarboxylase (GAD), GLU converts into GABA in the pre-synaptic terminal. The 
GABA-GLU cycle is illustrated beautifully in Figure 2-1.Some GABA is uptaken by the 
glial cells with the help of GABA- transaminase (GABA-T) enzymes. This is also shown 
in Figure 2-1. 
GLU and GABA maintain healthy balance in the brain by means of Glutamate 
(GABA)-glutamine cycle. The main feature of this cycle is: upon depolarization and 
vesicular release of Glu, it is uptaken into astrocytes by high affinity transporters [25]. 
Astrocytic GLU is turned into glutamine by the amination process. Interestingly, this 
process can only happen in astrocytes.  Glutamine is not known to be neurotoxic and 
therefore it can be safely transported out of the astrocytes. Intracellular and extracellular 
GLU concentration typically ranges in the micromolar range. However, tissue and blood 
fluids sometimes also show high GLU concentration. Similarly, In the brain GABA 
concentration is in the range of nM to lower mM [26], [27]. For rat brain slices the 
concentration of GABA is reported as 20-70µM [28]. However, with magnetic resonance 
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spectroscopy in human brain GABA concentrations was found to be 1-1.2μM [29]. 
Abnormal level of GABA and GLU  is an underlying cause of brain disorders such as 
epilepsy, Parkinson's, Alzheimer’s, traumatic brain injury and drug addiction [2], [6]–[8], 
[30]. 
 
Figure 2-1: GABA cycle in the brain. Adopted from [31] 
 
2.2 Current Methods for Neurochemical Detection 
Different methods are available for measurements of neurochemicals. Based on 
the mechanism principles, these methods can be invasive or non-invasive. As expected, 
different methods have different advantages and disadvantages. The comparison helps us 
to select the right approach required for the particular application. Table 2-1 gives a brief 





Method Advantages Disadvantages 
Electrochemical 
microsensors  
High temporal resolution 
(<1 s) 
Low detection limit (<1 
µM) 
High spatial resolution 
(<100 µM) 
Invasive 
Limited lifetime (< 60 days)  
Small number of analytes  
Microdialysis Very low detection limit 
(<1 nM) 
Large number of analytes  
Invasive 
Low temporal resolution 
(minutes) 
Complicated setup to 




Direct chemical structure 
detection 
Low precision and costly 
large equipment 
High detection limit (mM) 
Low temporal resolution 
(minutes) 





Low detection limit (<1 
µM) 
Large number of analytes  
Radioactive exposure and 
costly setup 
Low temporal resolution 
(minutes) 
Low spatial resolution (up 
to mm3) 
Fluorescence imaging  Very low detection limit 
(<1 nM) 
High temporal resolution 
(<1 s) 
Very High spatial resolution 
(<1 µM)  
Indirect via biomarkers 
Complex chemical 
properties of biomarkers 
Separate optical equipment 
needed  
 
Table 2-1: Comparison of different methods for neurochemical detection adopted from [32] 
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2.2.1 Microdialysis 
Microdialysis is the most widely used method for in-vivo measurements [32]. It is 
based on the principle of semipermeable membranes. These membranes restrict diffusion 
of the molecules by means of diffusion gradient[33]. An invasive probe is inserted in the  
brain and the extra-cellular fluid is pumped out for offline analysis [32] with other 
complementary methods like chromatography or fluorescence imaging. Microdialysis can 
measure small sample sizes (<10 μL) that allows for very low detection limit in 
nanomolar range [34]. Researchers can study simultaneous neurochemicals with this 
method. To date, in-vivo GABA levels are detected mainly via microdialysis on a high-
performance liquid chromatography (HPLC) system with electrochemical (EC) and 
spectroscopic detection methods [35]–[38]. Since these methods are relatively insensitive 
to GABA, one must derivatize the solution, i.e., modifying them to be more conducive to 
electric signals. Several studies have been used HPLC with pre/post derivatized columns 
using 2,4,6-trinitrobenzenesulfonic acid, o-phthaldialdehyde (OPA)-sulfite and OPA-
alkylthiols to separate GABA and other amino acids and then applied electrochemical 
detection on a glassy carbon electrode (GCE) to detect them at picomolar concentrations 
in rat brains [18] . The idea of OPA-butylthiol was first proposed by Kehr who further 
infused nipecotic acid and 3- mercaptopro-pionic acid to obtain a faster and more 
sensitive determination of GABA [35]. Rowley et al. extended this derivatization 
technique to separate seven amino acids and concluded that their method has the 
sensitivity to successfully detect stimulated levels of GABA and glutamate (Glu), a major 
excitatory neurochemical in a rat hippocampus[36]. Acuna et al. also used this method to 
separate GABA, Glu and glutamine in rat brain homogenates with higher accuracy and 
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repeatability [37]. Reinhoud used microbore columned Ultra-HPLC to detect 
catecholamines such as dopamine (DA) and serotonin (HT-5) [38].The main benefit of 
this method was that analytes with large differences in retention time could be separated 
in a single run [38].Commercial HPLC-ED systems (Alexys, Dionex) are now available 
that utilize GCEs at ∼0.8 V for amino acid detection. This current state of the art 
technology is bulky and unsuitable for real-time continuous GABA monitoring, which is 
a key technology gap in the chemical neuroscience field. However, despite all these 
advantages there are several shortcomings for microdialysis when it comes to in-vivo 
application. The main disadvantage of microdialysis is the low temporal resolution. In 
this method the sample is collected over minutes, whereas neurochemical transmission 
lasts in the order of milliseconds or seconds [39]. For this reason, the events of 
neurochemical release and uptake gets mixed with each other, which is a loss of temporal 
resolution. This phenomenon also makes the study of behavior patterns and disease 
models that depend on sub-second resolution difficult to accomplish with this method.  
2.2.2 Nuclear Magnetic Resonance (NMR) 
NMR spectroscopy uses frequency spectra to specify chemical structure of 
molecules. The structure is used to identify chemical compounds. This is also a desirable 
method for clinicians since it is a minimally invasive process. The frequency spectra 
reveal the exact chemical structure which can visually inspected using proton imaging 
techniques. However, the low temporal resolution and the need for high volume sample 
required make this method unsuitable for some specific application. Additionally, this 
method can’t distinguish between molecules of similar chemical structure (e.g. glutamate 
and glutamine).  Molecular labeling maybe required for those situations [40], [41]. 
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2.2.3 Positron Emission Tomography (PET) 
In this method a radioactive substance is perfused in the tissue. The resulting 
radiation is detected. Since this method is also non-invasive [32], it is of importance to 
the clinicians. However, the main drawback of this method is the limited availability and 
lifetime of the radioactive tracers. Sometimes these tracers are metabolized directly in the 
cells without ever detecting our molecule of interest [32]. Additionally, this method is 
limited by spatial resolution [42], [43] and low temporal resolution[44]. The long-term 
effects of these radioactive tracers also need to be evaluated. 
2.2.4 Optical Methods 
Optical enzymatic or non-enzymatic biosensors based on fluorescence or 
spectroscopy and their relevant principles is discussed widely in the literature [45], [46].  
These methods are mostly restricted to animal models. Lack of appropriate dyes, optical 
path length and interferences often hinder optical sensor methods [32]. In recent years 
fluorescence markers for different neurochemicals have emerged [47], [48]. Glutamate 
binding protein and fluorescent protein is introduced in the cells and multiphoton 
microscopy is used to analyze results [49]. This gave acceptable spatio-temporal 
resolution [49]. However, complex mechanism to accommodate this biomarker into the 
organism, non-linear fluorescence signal and the need for integrating high-resolution 
imaging system makes these optical methods unsuitable for clinical use, especially in-
vivo use. Spectroscopic based on UV-Vis methods has also been demonstrated for 
various neurochemicals [50]. 
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2.2.5 Electrochemical Sensors 
Electrochemical sensor is based on the direct/indirect oxidation/reduction of the 
molecules on the surface of the sensor. The sensor surface can be as small as a few 
microns. We call these sensors microelectrodes. Electrochemical sensors are available for 
most neurochemicals, including dopamine, glucose, glutamate and GABA. These are 
widely used in commercial purposes as well as clinical purposes. The most widely 
available application of electrochemical sensors is the glucose sensor.  
Electroactive molecules comes in direct contact with the sensor surface and we 
immediately see a change in electrical signal [6], [51], [52]. The quick response in the 
form of change in signal gives electrochemical sensors higher temporal resolution than 
micro dialysis, NMR, PET. It also means we can resolve signals in behavior patterns and 
neuron firing in the milliseconds to seconds range.  In some cases, if the molecules are 
not electroactive, not capable of directly oxidizing in the sensor surface, we can modify 
our sensor surface with appropriate materials (e.g. enzymes) to facilitate the oxidization. 
This capability makes electrochemical sensors powerful in detecting almost all 
neurochemicals. Advanced microfabrication techniques can be employed to make sensors 
every geometrical shape imaginable. These sensors can also be employed in in-vivo, ex-
vivo and cell culture environments. The main disadvantage of these electrochemical 
sensors is that they have limited lifetime because the surface coatings foul with time [32].  
In the subsequent section, we discuss electrochemical methods for neurochemical 
detection. 
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2.3 Electrochemical Methods for Neurochemical Detection 
Electrochemical methods depend on the interaction between the electrode 
materials and molecules. The general mechanism is: when the molecule comes in contact 
with the sensor (electrode) surface, it gives away electrons. This electron gives rise to 
current which can be visualized and analyzed with advanced computational tools. This 




Figure 2-2: General mechanism of electrochemical process 
The predominant method we use here is chronoamperometry. In 
chronoamperometry we bias the electrodes with a constant potential against a reference 
electrode. The mechanism of chronoamperometry is simple: monitor a gain or loss of 
electrons and measure the subsequent faradaic current. Chronoamperometry is governed 





 Eq. 2-1 
Here, i is recorded current (𝑛𝑛); n is the number of electrons transferred; F is the 
Faraday constant (96485 𝐶𝐶
𝑚𝑚𝑚𝑚𝑚𝑚
); A is the electrode area ( 𝑚𝑚2); C is substrate concentration 
(𝑚𝑚𝑚𝑚𝑚𝑚
𝑚𝑚3
); D is mass transfer coefficient (𝑚𝑚
2
𝑠𝑠
); and t is time (𝑠𝑠). As the equation suggests, the 
current depends on the concentration of our analyte. Figure 2-3 shows a sample 
chronoamperometry graph. As we expect when we inject our sample of interest the 
current level goes higher. This assumed linear diffusion of oxidized/reduced species is 
very desirable for a sensor.  
 
Figure 2-3: Sample chronoamperometry signal. The current level increases with 
each analyte addition. The red triangles indicate each analyte addition. 
We can easily make the current vs concentration graph from the 
chronoamperometry plot. From the current vs concentration curve, we can get sensitivity 
and limit of detection (LOD) for the sensors. We can also get the linear range from the 
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data. The rise time (T10-90), decay time (T90-10) and full duration half maximum (T50-50) of 
changes in current can also be determined from chronomperometry results. However, the 
main limitation for this method is the non-selective oxidization (or reduction) of 
molecules in the sensor surface. Through the fine tuning of applied voltage and judicious 
surface modification can remedy this problem. This method has been used in 
measurement in cell culture [53], [54] and  in-vivo environments [55], [56].The other 
method we use throughout our work is cyclic voltammetry (CV A sample CV graph is 
shown Figure 2-4. 
 
Figure 2-4: Sample CV graph. The arrows show the forward and backward sweep. 
Epa= anodic potential, Epc= cathodic potential, ipa= anodic current and ipa= cathodic 
current. CV is done in 8-TRK probes and 5mM ferro/ferri cyanide. 
The peak current for forward sweep current, i is governed by Randle-Sevcik 
Equation shown in Eq. 2-2 below: 
 𝑖𝑖 = (2.69 ∗ 105)√𝑛𝑛 3  𝑛𝑛√𝐷𝐷𝐷𝐷 𝑛𝑛 Eq. 2-2 
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Here i is the measured current in amperes, 𝑛𝑛 is the number of electrons transferred 
during the redox process, 𝑛𝑛 is the area of the electrode’s surface(𝑐𝑐𝑚𝑚2), 𝐷𝐷0 is the 
diffusion coefficient of the analyte (𝑐𝑐𝑚𝑚
2
𝑆𝑆
), 𝐷𝐷 is the scan rate (𝑉𝑉
𝑠𝑠
)and 𝑛𝑛0 is the concentration 
of the analyte expressed in(𝑚𝑚𝑚𝑚𝑚𝑚
𝑐𝑐𝑚𝑚3
). 
CV gives information about the electron transfer kinetics, electrochemical 
diffusion process and adsorption process. CV and particularly a variation of CV called 
the fast scan cyclic voltammetry (FSCV) is very popular for in-vivo applications[57]. A 
higher scan rate facilitates rapid electron transfer on the electrode surface which is highly 
desirable live-animal experiments. FSCV has been used to monitor various 
neurochemicals like dopamine [58], serotonin and pH level changes [59]–[61]. The fast 
scan also suggest that this method can be used to study real-time release and uptake of 
neurochemicals [62], [63]. In our works we use CV for mild sulfuric acid (H2SO4) 
cleaning and permselective layer coating. CV can also be used to measure electroactive 
surface area. We used chronoamperometry for other sensor calibration. 
2.4 Microelectrodes for Neurochemical Sensing 
Microelectrodes are electrodes with dimensions typically in the micron range 
(≤25 μm).  It has several advantages over the macroelectrodes (which are in the 
millimeter range)[64], [65]. Firstly, in these micro-electrodes the redox reaction in the 
sensor surface is independent of the analyte concentration in the solution [66]. Secondly, 
since ohmic voltage drop is minimal we can  keep the currents in picomolar range [66]. 
This is highly desirable for measurement of very low concentration of neurochemical. 
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Finally, the dominant diffusion process in these electrodes is the radial diffusion which 
always result in higher charge density and higher selectivity [66]. 
Electoactive neurochemicals (dopamine, serotonin) oxidize directly in the 
electrode surface resulting in amperometric current signals. However, GLU and GABA 
are is non-electroactive, and it is therefore challenging to detect it in real-time using 
electrochemical (EC) and spectrophotometrical methods [67]. The most common 
approach for electrochemically detecting these molecules is to enzymatically convert 
them to an electroactive reporter molecule (e.g. hydrogen peroxide or H2O2, NADPH) 
with an appropriate enzyme immobilized on the surface of the electrode [3], [68], [69]. 
These enzymes are usually oxidase enzymes. The most famous enzyme based electrode is 
the glucose sensors based on glucose oxidase [4]. Glucose sensors are now a billion-
dollar commercial industry that serves the diabetes patients. Additionally, lactate oxidase 
[70], glutamate oxidase [12] or choline oxidase [71] based sensors are also available. 
These enzyme-based biosensors also evolved overtime. 
In the first-generation biosensor, enzymes convert the molecule, in presense of 
oxygen, into reporter molecule (H2O2). This sensor needs oxygen to function. However, 
oxygen is available in lower concentrations in tissues because of restricted supply by 
blood vessels [32]. This low oxygen concentration severely limits diffusion capability 
when the analyte concentration becomes too high [32]. In our works we use the first-
generation biosensor. 
To eliminate this oxygen dependency, researchers developed second-generation 
biosensors. This is a regentless sensor where they use electron acceptor instead of oxygen 
[72].  Basically, in this method enzyme is reduced and substrate turns to product. This 
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reduced form of enzyme reduces the mediator and then oxidized by electron from nearby 
molecule [32]. The final step involves oxidation of mediator in the electrode surface [32]. 
Redox polymers which are capable of containing both enzyme and mediator molecules 
are used in this type of sensors [73], [74]. The third-generation biosensors the electron 
transfer happens directly in the surface from the enzyme without any oxygen or mediator 
molecule. However, Wang et. al., 2008 showed in from their work these sensors are 
severely limited in their efficiency [72]. 
Our sensors are based on the first-generation sensor working principle. There are 
several GLU sensor based on this principle is available [75]–[77]. In Figure 2-5, we show 
several pathways for GABA detection scheme. However, because of absence of an oxidase 
enzyme that can directly oxidize GABA, GABA detection is more challenging. Biosensors 
selectively oxidize GABA into a secondary product (GLU) and then oxidized into a 
reporter molecule in the presence of enzymes, similar to the detection method used for Glu 
[78] or acetylcholine [79]. Electroactive reporter molecules such as β-nicotinamide adenine 
dinucleotide phosphate (NADPH) or hydrogen peroxide (H2O2) are usually generated 
through a series of enzymatic reactions by adding nicotinamide adenine dinucleotide 
phosphate (NADP), a co-factor or by adding α-ketoglutarate and then electrochemically 
detecting them on a modified glassy carbon electrode GCE. The current generated by 
electrochemically oxidizing them can be used as an index to quantify GABA. In AM-based 
GABA biosensors, GABASE, which consists of two enzymes, γ-aminobutylate 
ketoglutarate aminotransferase (GABA-T) and succinic semialdehyde dehydrogenase 
(SSDH) converts GABA into GLU (henceforth called GLUGABA) and succinic 
semialdehyde (SSA) in the presence of α-ketoglutarate (reaction 1). For reaction 1 to occur, 
20 
α-ketoglutarate must be present in the sample. The α-ketoglutarate can be added to the 
sample externally or it can be obtained from oxidizing Gluthat is ubiquitously present in 
the brain microenvironment (henceforth called GluE/GLUE) using the glutamate oxidase 
(GOx) enzyme (reaction 2). Subsequently, there are two pathways by which reaction-1 can 
proceed to generate electrochemically or optically active molecules that are detected as a 
GABA signal. The first approach is based on SSA reacting with NADP in the presence of 
SSDH to form NADPH that is then detected optically (UV spectrophotometry or 
colorimetry [50]) or electrochemically (reaction 3). Mazzei et. al. developed a GABA 
biosensor based on reaction 3 using a horseradish peroxidase-modified GCE [80]  
However, the  main disadvantage of reaction 3 are that the electrode surface fouls rapidly 
due to the irreversible nature of NADP+ adsorption. Sekioka et. al., partially addressed this 
challenge using an electron cyclotron resonance (ECR) sputtered carbon electrode [13]. 
Since there is a critical need for ex vivo and in vivo studies to detect GABA long term and 
NADP to NADPH conversion is irreversible, NADP must be continuously replenished. 
Badalyan et.al., addressed this problem of continual NADP additions by employing 
periplasmatic aldehyde oxidoreductase instead of SSDH and mediators such as 
ferricyanide, phenoxazines, ferrocene derivatives, quinones and bipyridinium salts instead 
of NADP[81]. The SSA generated in reaction 1 is converted to SA when periplasmatic 
aldehyde reductase is present on the electrode surface (reaction 5) [26]. 
Niwa et al. employed a very different approach that relied on GOx to convert the 
GluGABA generated in reaction 1into α-ketoglutarate and H2O2 (henceforth called 
H2O2(GABA), i.e. H2O2generated from the Glu that in turn is generated from GABA) 
(reaction-4) and then detecting it on an osmium-poly(vinylpyrridine) gel-horseradish 
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peroxidase-modified GCE [11]. Applying reactions-1 and reaction-4, researchers were 
able to detect GABA with adequate sensitivity and selectivity in the presence of DA, 
serotonin (HT-5) and ascorbic acid (AA). However, both approaches are incapable of 
continuously monitoring the changes in GABA levels in real-time since they require 
additions of reagents such as NADP and α-ketoglutarate. A biosensor technology that can 
accurately measure GABA in real-time and continuously without any external 
intervention is technically challenging and therefore as yet unrealized. Detailed recation 
pathways are shown in Figure 2-6. 
 





2.5 Working Mechanism and Sensor Design Considerations 
2.5.1 Reaction Pathways 
 
 
Figure 2-6: Reaction pathways for different sites and related reactions [14]. 
In this work, we report the development of a novel GABA probe based upon 
platinum (Pt) microelectrode array (MEA). The GABA probe uses two types of 
microbiosensors, namely a GLU microbiosensor located in Site 1, Figure 2-6 ) and a 
GABA microbiosensor (located in Site 2, Figure 2-6) that are uniquely modified with 
GOx only at Site 1 for reaction 1 to occur and with GOx and GABASE at Site 2 for 
reactions 1, 2 and 4 to occur. The two sites should be very close to each other, distance 
between them should be close. By simultaneously measuring and subtracting the 
oxidation currents of H2O2 generated from the two microbiosensors, current of H2O2(E) at 
Site 1 (henceforth called H2O2(Site 1)) and H2O2 from H2O2(E) and H2O2(GABA) at Site 2 
(henceforth called H2O2(Site 2)) GABA (IGABA = ∆I = H2O2(Site 2)−H2O2(Site 1)) can be 
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detected in real-time continuously ( Figure 2-6) without adding α-ketoglutarate externally 
(Figure 2-6). This is possible because α-ketoglutarate generated in reaction 2 is used in 
reaction 1. This scheme can be readily implemented in vivo because the ubiquitous 
presence of Glu allows in-situ generation of α-ketoglutarate and thus, reaction 1 to occur 
continuously. Additionally, we prepare a blank electrode without any enzyme as our 
control. This electrode will detect neither GABA nor GLU. This electrode will only 
detect signals resulting from common, electrically active intereferent molecules like 
ascorbic acid. In case of wire we call this the “sentinel channel”, which is further 
described in CHAPTER 5. In presence of a sentinel channel, our probe becomes truly 
self-referencing. The current at the sentinel channel is then subtracted from the GABA 
and Glu channels at each time point. This minimizes the effects of these environmental 
signals, thereby greatly improving the selectivity of the GABA and GLU channels. 
Our material of choice for our sensors is platinum because it has high catalytic 
activity for oxidation of H2O2 (our reporter molecule). Platinum is also a general choice 
in enzymatic biosensors [12], [68], [69], [78]. Platinum electrodes are fabricated and 
commercialized in both shank style probes and microwire-based platform devices. 
Combining a series of microfabrication techniques platinum electrodes have been 
implemented in substrates like silicon [71] and ceramic [82]. Sensors based on polymer 
substrates are also available[83], [84]. The main concern with these sensors is their 
fragility. These probes break during penetration in the tissue. Other limitation is most of 
the times these sensors are arranged vertically which make spatial recording impossible. 
For those reasons sometimes wire based electrodes are used. Wires are easily modifiable, 
low- cost alternative to commercial sensors. It is also easily implantable in brain and 
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applications are available in literature [85], [86]. However, microfabricating wires for 
simultaneous monitoring of more than one neurochemical still remains a challenge. Other 
limiting mechanism is the enzyme coating procedure. Dip coating is generally used 
which allows for only partial spatial control [32]. 
2.5.2 Enzyme Immobilization 
Immobilization of enzyme in the sensor is the most important step of any 
biosensor integration. The enzyme needs to form a stable layer in the sensor surface 
without loss of activity. A simple layer of enzyme is kinetically limited because of 
catalytic occupation of its molecules [32]. To solve this problem, we need a protein 
matrix that has higher loading (for enzymes) without loss of signals. In literature 
immobilization is done by cross-linking with a homo bifunctional molecule 
(glutaraldehyde)  and protein matrix (bovine serum albumin, BSA) [12], entrapment in 
hydrogel matrix [87] or integration into a electrodeposited polymer [88], [89]. 
Comparison of these methods is presented in literature [32]. Cross-linking with BSA and 
glutaraldehyde gives the highest sensitivity in commercial platinum electrodes. The main 
drawback of cross-linking method is the limited lifetime of these sensors. A decrease in 
sensitivity is reported in the literature [83]. However, fine tuning enzyme concentration a 
sensor which is stable for at least a month have been reported [90]. 
2.5.3 Selectivity and Interference Rejection 
Typically, selectivity refers to the ability of the sensors to produce high signal for 
the measured analyte and low signal for the unspecified molecules. It is an important 
consideration for in-vivo measurement because lots of chemical are present in the brain. 
Chronoamperometry is not selective method, meaning if any electroactive molecules 
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come in the contact of the surface, they get oxidized and produces current in constant 
potential. To maximize selectivity, we need mechanism that can stop the reaction 
between interferent molecule and the sensor surface. The most frequently used method is 
the use of size-exclusion layer like m-phenyldiamine (mPD [91]) or nafion [92]. These 
layers work on a simple method: it lets small molecule like H2O2 pass and blocks bigger 
molecules like ascorbic acid. Typically, these polymers are deposited electrochemically 
(cyclic voltammetry). While this method can prevent the interferent molecules, the trade-
off here is the loss of sensitivity. Selectivity is measured by the ratio of sensitivity for the 
analyte divided by sensitivity of interferent.   Higher the value suggests greater 
selectivity. Typically, selectivity value of ≥35 is desirable.  Other commonly used 
method for interference rejection is the blank electrode or self-referencing method. In this 
method, an electrode without enzyme is placed in proximity to another enzyme-based 
working sensor. In the final phase, the current from this blank is subtracted from the 
working sensor. In the in-vivo application where background signal fluctuate often, blank 
electrode can be useful.  
Throughout this dissertation we used various platforms for our sensors. The 
enzyme immobilization was done using the matrix of BSA and glutaraldehyde. An mPD 







MATERIALS AND METHODS 
 
3.1 Chemicals and Enzymes 
Phosphate buffered saline (PBS), bovine serum albumin (BSA), glutaraldehyde, 
GABA, GABASE from Pseudomonas fluorescens, L-glutamic acid monosodium hydrate, 
ascorbic acid, hydrogen peroxide, choline, acetylcholine, dopamine, uric acid, seratonin 
(5-HT) and α-ketoglutarate disodium salt was purchased from Millipore-Sigma (MO, 
United States). All chemicals were reagent grade unless otherwise specified. Glutamate 
oxidase, recombinant lyophilized powder (9.3 U/mg), was purchased from Cosmo Bio 
Co., LTD (Carlsbad, CA, USA).  
3.2 Microelectrode Array 
3.2.1 8-TRK Commercial Platinum Microelectrode Array 
Microsensors were prepared based on 8-TRK-type microelectrode arrays (Center 
for Microelectrode Technology, University of Kentucky, Lexington, KY). 8-TRK 
MEA consisted of eight  platinum sites (50 µm × 100 µm, 100 µm boundary-to-boundary 
spacing for sites within a pair and 1, 1, 2 mm distance for between pairs, Figure 3-1) on a 
ceramic substrate (127 µm Al2O3) that employed a thin polyimide as a passivation layer. 
The fabrication process of these commercially available electrodes is described in 
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literature [3], [82], [93]. Electrode sites, connecting lines, and bonding pads were 
patterned onto a photoresist-coated 2.5 cm × 2.5 cm ceramic substrate by exposing the 
photoresist with collimated UV light through a mask. Using sputter coating system, a 500 
Å adhesion layer of titanium and a 2300 Å layer of elemental Pt (Pt°) were coated in the 
ceramic substrate to perfectly define the electrode site, connection line and bonding pads. 
Besides the MEAs, all circuits were insulated with approximately 1.2 μm layer of 
polyimide to protect against aqueous environments and reduce charging current. 
Individual microelectrodes were sawed from patterned wafers using a computer-
controlled diamond saw and were connected to printed circuit boards. Eight contact pads 
were located on the other side of the ceramic substrate which enables the probe to 
connect with our electrochemical system (FAST system, mkIII, Quanteon, KY, USA). 
 
Figure 3-1: Optical picture of 8-TRK-type microelectrode arrays. A. Shows the whole 
probe with the connection pads, electrode sites. B. Shows zoomed in version of the 
eight electrode sites [14]. 
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Some salient features of this probe in the context of our research are:  
1. eight individually electrically addressable Pt microelectrodes that can 
easily be multiplexed to simultaneously measure other important 
neurochemicals, such as Glu, DA, adenosine and HT-5, through suitable 
surface modifications, which is not possible with other commonly 
available electrodes for chemical sensing, e.g., carbon fiber 
microelectrodes;  
2. GABA and GLU microbiosensors can be placed in close proximity to 
provide precise measurements of local GABA level changes;  
3. The ability to detect GABA-GLU in real-time without adding reagents 
(i.e., truly self-contained);  
4. The location of MEAs along the long shank allows GABA sensing at 
multiple depths in the brain; and  
5. Allows simultaneous sensing of neurochemicals and field potentials for 
multimodal recordings, which is not possible with the current 
neurochemical technologies. 
In our initial sensor development phase, we exclusively used these MEA shown in 
detail in Chapter-4. Initial ex-vivo experiments to get GABA and GLU concentration 





3.2.2 Wire based Platinum Microelectrode array 
We have developed a platinum (Pt) microwire biosensor probe that can is easily 
fabricated in a lab that has electrochemistry expertise. Our biosensor probe is composed 
of three Pt microwires to detect GABA, GLU, and interferents respectively. The GABA 
biosensor is based on a novel process that does not require the addition of substrates, 
which makes it easier to use for in-vitro[94] and ex-vivo[14] applications and which 
enables in vivo recordings[15], [94]. Additionally, when the ends of the microwires are in 
the same plane, as we report here, the geometry is suitable for placement into cell culture 
dishes and brain slices. It is also optimal for in vivo recording in brain regions with 
laminar structure, such as the cerebral cortex and hippocampus in animals.  
Our microwire biosensor design is not only advantageous for future, longitudinal 
in vivo recording, its geometry has distinct advantages over shank-style neural recording 
probes for brain slice and cell culture models. Shank-style probes are designed to record 
electrical signals from different regions of the brain for in vivo studies. In contrast, brain 
slices are cut thin and placed horizontally in a recording chamber to extend tissue 
viability and function. Thus, a geometric profile in which all of the microwire biosensor 
sites contact the slice in the same horizontal plane provides an advantage. Similarly, 
cultured cells for in vitro models grow in a thin layer on a flat cell culture dish. Again, a 
microwire biosensor in which all probe sites are in a horizontal plane equidistant from the 
cells is a desirable arrangement. In our previous studies, we experienced difficulties in 
using shank-style microbiosensor arrays when recording from brain slices[14] and 
cultured cells[94]. When recording in brain slices, we could only use two of the eight 
sensor sites on a shank-style probe; the same was true for cell culture recording. 
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Fabrication of microwire biosensors in-house offer several advantages. They are 
as follows:  
1. The mPD layer can be coated on the outside for longer sensor life for in 
vivo applications, or on the inside for higher sensitivity, short-term use.  
2. Additional wires can be added and placed at different depths for recording 
in more than one brain area or region. 
3. Pt microwires are relatively inexpensive and easy to coat compared to 
high-density shank arrays.  
4. It is relatively easy to change the geometrical area of the biosensors by 
simply changing the Pt microwire diameter.  
5. A high-density probe (up to 8 biosensors) can be assembled with thinner 
wires to create a probe diameter of less than 300 microns. This should 
result in minimal inflammation, which is a desirable biosensor 
characteristic for in vivo recordings. The ease of handling the microwire 
biosensor with the microwires banded together provided the strength and 
stability to insert it into a cannula for real time in vivo recording. The 
ability to remove it and replace it with a fresh biosensor facilitated a pilot 
long-term study of GLU and GABA dynamics with high temporal 
resolution in the hundreds of ms. 
The details of fabrication, wire selection and characterization are described in 
detail in Chapter-5. The ex-vivo and in- vivo results from our wire-based microarray is 
discussed in Chapter-6. 
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3.3 Biosensor Preparation 
3.3.1 Electrode Preparation 
To coat the 8-TRK probe for GABA and GLU electrodes, we modify two sites 
(pairs). Site-1 is designated for GLU electrode and is coated with Glutamate oxidase 
(GOx) only. Site-2 is designated for GABA electrode and is coated with GOx and 
GABASE. This is shown in Figure 3-2. 
 
Figure 3-2: The probe at higher magnification showing 6 of 8 Pt microelectrodes. 
Each site has two modified microelectrodes. For this work, Site 1 is modified with 
Gox (Glu microbiosensor) and Site 2 is modified with GOx and GABASE enzymes 
(GABA microbiosensor). Each Pt microelectrode is 100 µm × 50 μm. The distance 
between the sites is 1 mm [14] 
In case of wire-based microelectrode arrays, we modify first wire as the GABA 
channel with GABASE and GOx, second wire as GLU channel with GOx only and third 
wire as sentinel channel with BSA and glutaraldehyde (no enzymes). We discuss the 
fabrication and characterization in Chapter-5. 
3.3.2 Enzyme Aliquot Preparation 
The GOx enzyme with the BSA and glutaraldehyde was coated in Site 1 as per 
literature [12].  For GLU sites (channels), the GOx enzyme was mixed in DI water to 
prepare aliquots of 0.5 U/μL and stored in -80°C. Prior to coating, they were thawed first 
at 4°C and then at room temperature. DI water (985 μL) was added to 10 mg BSA in a 1 
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mL centrifuge tube. After allowing the BSA to dissolve, 5 μL of glutaraldehyde (25% in 
water) was added to the solution. We kept the solution mixture (1% BSA and 0.125% 
glutaraldehyde) at room temperature for ∼5 min. A 4 μL of the mixture was added to 1 
μL of GOx (0.5 U/μL) and centrifuged to form the final enzyme-matrix mixture of 0.1 
U/μLGOx/0.8% BSA/0.1% glutaraldehyde.  
Similarly, for GABA sites (channels), DI water (986.7 μL) was added to 13.33 
mg BSA in a 1 mL centrifuge tube. After allowing the BSA to dissolve, 6.67 μL of 
glutaraldehyde (25% in water) was added to the solution. We kept the solution mixture 
(1.33% BSA and 0.166% glutaraldehyde) at room temperature for ∼5 min. Next, 3 μL of 
the mixture was added to 1 μL of GOx (0.5 U/μL) and 1 μL GABASE (0.5 U/μL) and 
centrifuged to form the final enzyme-matrix mixture of 0.1 U/μLGOx/0.1 U/μL 
GABASE/0.8% BSA/0.1% glutaraldehyde. For the GABASE-only site, the procedure 
used for GLU site (channel) was followed except that GABASE instead of GOx was 
used. 
For sentinel channels, in case of wires, DI water (985 μL) was added to 10 mg 
BSA in a 1 mL centrifuge tube. After allowing the BSA to dissolve, 5 μL of 
glutaraldehyde (25% in water) was added to the solution. We kept the solution mixture 
(1% BSA and 0.125% glutaraldehyde) at room temperature for ∼5 min. At this point, we 
coat the wires with this solution. No enzymes were present in this mixture. 
3.3.3 Enzyme Coating Procedure 
Under a Nikon stereomicroscope (Model, SMZ18), three drops (0.05 μL/drop) of 
the respective enzyme-matrix mixture was applied manually at each site using a 
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microsyringe (Hamilton®, Model 701 N). Then the probe was stored for 48 h in an 
aluminum foil covered storage container with no exposure to light prior to use. 
3.4 Reference Electrode 
Ag/AgCl is used as our reference electrode for amperometric measurements. 
Teflon-coated Ag wire was purchased for this purpose (wire diameter-200 µm bare, 280 
µm coated; A-M Systems, Carlsberg, WA, USA). To prepare this reference wire, one 
side of the silver wire was exposed 2 mm using a scalpel and then soldered to a copper 
connection pin (Tin soldering, Radioshack, USA) and the other side of the silver wire 
was exposed approximately 1 cm. This silver wire was then used as an anode with the 
silver part immersed in saturated NaCl in 1 M HCl, and a platinum wire was used as a 
cathode. A +9 V potential was applied to this 2-electrode system using a Gamry reference 
600 workstation for 20 minutes. Prepared Ag/AgCl wire was then rinsed with DI water 
before use. This Ag/AgCl is stored in room temperature at 3MNaCl solution. 
3.5 Electrochemical Measurements 
For amperometry measurements, a multichannel FAST-16mkIII® potentiostat 
(Quanteon, LLC, Nicholasville, KY, United States) in a 2-electrode setup was used with 
an Ag/AgCl electrode as the reference electrode, our microelectrode array (8-
TRK/microwires) is our working electrode. The general setup and the experimental setup 
are shown in Figure 3-3. The applied potential was set at +0.7 V for H2O2 detection. 
Note: This applied potential can be reduced to +0.3 V vs. Ag/AgCl when modified using 
platinum black as reported in the literature [95]. The recording frequency was 2 Hz. All 
solutions were freshly prepared on the same day that the experiments were conducted. 
The experiment was carried out in a 40 mL buffer solution. The analytes were introduced 
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into the solution using a syringe pump (KD Scientific, Legato® 100 syringe pump) to 
obtain the desired concentrations (M). The solution was continuously stirred at 200 rpm 
and maintained at 37°C. All measurements were repeated at least 3 times. In 
amperometry calibration for the beaker experiments, 5-10 mins was usually given to 
obtain a stable baseline. 
 
Figure 3-3: Chronoamperometry experimental setup A. shows the schematic diagram 
of our setup. B. Experimental setup of our beaker experiments. WE: working 
electrode (8-TRK/microwires), RE: reference electrode (Ag/AgCl). 
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3.6 Recording GABA and GLU in Brain Tissue 
3.6.1 Animal Care and Use 
Male Sprague Dawley rats were housed on a 12 h on – 12 h off cycle with food 
and water provided ad libitum, according to a Louisiana Tech University IACUC 
protocol, the Guide for the Care and Use of Laboratory Animals and the AVMA 
Guidelines on Euthanasia. 
3.6.2 Hippocampal Slice Preparation 
Hippocampal slices were prepared from an adult Sprague Dawley rat that was 
anesthetized using 5% isoflurane gas prior to decapitation and rapid removal of the brain. 
The brain was immediately placed into ice cold artificial cerebrospinal fluid (aCSF) 
containing (in mM): 135 NaCl, 3 KCl, 16 NaHCO3, 1 MgCl, 1.25 NaH2PO4, 2 CaCl2, and 
10 glucose, bubbled with 95% O2/5% CO2 (carbogen) [96]. The slicing chamber of an 
OTS-5000 tissue slicer (Electron Microscopy Sciences) was filled with aCSF at 4° C and 
then 500-μm thick coronal sections were cut and transferred to a holding chamber filled 
with aCSF maintained at 35°C and bubbled with carbogen. Slices were incubated for at 
least 60 min prior to recording. Thereafter, one slice was transferred to a liquid-air 
interface of a BSC1 chamber (Scientific Systems Design, Inc.) with the slice suspended 
on nylon net at the liquid-air interface with continuously dripping aCSF (37°C) bubbled 
with carbogen. Waste products were removed by continuous suction from the recording 
chamber Figure 3-4. 
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Figure 3-4: Setup for our  ex vivo experiments in a working chamber consisting of 
modified probe (microwire/8-TRK ), Ag/AgCl wire and tungsten wire as stimulus 
electrode, Photograph provided by P.T Doughty and T.A Murray, 2018 [14]. 
3.6.3 GABA Recording in Rat Hippocampal Slices 
The microbiosensors were coated with a size-exclusion polymer (m-
phenylenediamine, mPD) to prevent the interferents reaching the microbiosensor surface 
and to enhance the probe selectivity [97]. Chapter-4 and Chapter-5 shows the 
effectiveness of mPD layer to block intereferents. However, the trade-off is that we see a 
loss of sensitivity as well. The mPD layer was electrochemically deposited (cycling 
between +0.2 V and +0.8 V, 50 mV/s, 20 min in 10 mM mPD solution). A pair of 160 
μm diameter tungsten stimulation electrodes was placed in the Schaffer collateral CA1 
pathway within 200 μm of the microbiosensor probe sites [96]. A home-built, Arduino-
based signal generator [98] and a stimulus isolator (A365, World Precision Instruments, 
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USA) were used to deliver 100 μA current pulses to the slices. Two micromanipulators 
(M3301, World Precision Instrument, Hessen, Germany), an upright brightfield 
microscope (Eclipse E600FN, Nikon, Japan), and a custom, acrylic stage facilitated 
placement of the microwire biosensor in the pyramidal layer of hippocampal region CA1. 
Paired tungsten wire stimulation electrodes, 160-μm in diameter, were placed within the 
Schaffer collaterals, ~150μm from the microwire biosensor, as previously reported 
[14],[96]. For tissue slices recording with our 8-TRK probe we used five different types 
DC-signals with varying pulse-widths (duration of the pulse). However, for our tissue 
experiments with the microwire channels we programmed three types of 5 s pulse 
trainswith1-ms pulse width were programmed to deliver 10 Hz, 50 Hz, and 140 Hz 
stimulation and a single, 100 ms control pulse was also programmed. All these pulses 
were programmed and verified with an oscilloscope prior to our experiments. The 
motivation for selecting these stimulation frequencies were purely driven by clinical 
experience where 140 Hz stimulation is often used in deep brain stimulation (DBS) 
therapy against seizure or tremor, 50 Hz stimulation is used in direct cortical stimulation 
(DCS) to induce seizure while 10 Hz stimulation is used in transcranial alternating 
current stimulation (tACS) therapy. Current detected at the probe sites was plotted in real 
time. After the response current returned to baseline, we delivered a single 100 ms 
control pulse to assess the health of the slice and to verify that stimulations were not 
inducing potentiation. When the response current to a single pulse reached 80% or less 
than the mean response of the first three control pulses, the slice was discarded. 
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3.7 Awake-Free Rat Behavior Recording 
3.7.1 Microwire Guide Cannula Fabrication 
Each guide cannula was constructed from a 20-gauge stainless steel hypodermic 
needle with a plastic luer lock fitting (BD305125, Becton, Dickson and Company, 
Franklin Lakes, NJ). The hypodermic needle was blunt cut to a length of 2.8 mm, which 
allowed for its insertion into the hippocampus at the desired depth. A 25-gauge 
hypodermic needle (BD305175, Becton, Dickson and Company) was fashioned into a 
filler for the lumen of the guide cannula; the filler keeps blood and tissue from infiltrating 
into the guide cannula. To facilitate the insertion of the filler, most of the plastic luer lock 
fitting was removed using a Dremel MultiproTM using a circular 3.4 cm diameter cutting 
bit, leaving approximately a 1-2 mm section of the plastic fitting that surrounds the top of 
the needle. A 1mm hole was drilled into the center of a luer lock screw cap (51525K311 
nylon quick-turn cap, McMaster-Carr). The needle was passed through the hole in the cap 
until it reached the remaining portion of the plastic fitting. Cyanoacrylate adhesive was 
used to secure the needle to the cap. The needle was cut to a length that filled the guide 
cannula but did not protrude through it. For our guide cannula, the filler needle was cut to 
2.8 cm in length.  Needles were cut with a Dremel 3.4 cm diameter cutting bit and the 
ends were smoothed with a flat mill file of fine coarseness. An Ag/AgCl reference 
electrode was attached to the outside and parallel to the metal portion of the guide 
cannula using cyanoacrylate adhesive. The implanted end of the reference electrode was 
positioned at the end of the cannula. The connector end of this electrode was fashioned 
into a loop and pressed flat against the top of the luer lock fitting. The insulation on the 
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loop portion was removed to facilitate contact with the microwire biosensor for 
recording. When not recording, the filler cap covers the loop to prevent damage. 
3.7.2 Cannula Implantation 
A cannula, with the filler inserted, was implanted into the CA1region of the 
hippocampus, following a protocol approved by the Louisiana Tech University IACUC. 
To reduce stress, Male Sprague-Dawley rats were lightly anesthetized using isoflurane 
before an intramuscular injection of 75mg ketamine HCl and 0.25 mg dexmedetomidine 
HCl per 1kg of animal weight. Using aseptic techniques, a 3.5 mm diameter craniotomy 
was made 5.0 mm posterior from Bregma, 2.3 mm right lateral to the midline, and 2.8mm 
deep measured from the top of the skull. Four 1.50 mm stainless-steel anchor screws 
(Stoelting Co.) were implanted bilaterally along the outer edge of the scalp incision and a 
fifth screw located just anterior to lambda and 2.0mm laterally to the right of the sagittal 
suture as anchors for the implant. The cannula, with the filler inserted, was attached to a 
custom, 3D printed holder on a stereotaxic frame and lowered at 100 µm per min to the 
desired depth. The cannula and screws were secured using dental acrylic (Ortho-Jet 
BCA) which was applied to completely cover the bone screws, encapsulate the lower part 
the guide cannula fitting and sealed the exposed skull. Skin incisions were closed with 
interrupted sutures, and topical powder (Neo-Predef, Zoetis) was applied for antibiotic, 
anti-inflammatory, and analgesic effects. After this, the rat was given an IM injection of 
1mg/kg Atipamezole hydrochloride to bring the animal out of anesthesia and then 
monitored until it regained sternal recumbency. Rats were housed individually after 
surgery. Animals were given at least two weeks to heal before recording. 
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3.7.3 In vivo Recording 
Prior to recording, a rat was anesthetized in a chamber using 5% isoflurane for 5 
min. Immediately after removing the rat from the chamber, the filler needle was removed 
from the guide cannula and a sterile microwire biosensor array was inserted into the 
guide cannula. It was secured by twisting the luer lock cap on the microwire array; this 
also ensured contact with the reference electrode. (The filler was stored in 91% isopropyl 
alcohol during surgery. After recording, it was dried with a sterile tissue and reinserted.) 
The pin connector on the microwire biosensor array was inserted into the FAST 
potentiostat system and the reference wire connector pin was inserted into a separate 
channel on the potentiostat fitting. The rat was placed in a standard, clear plastic housing 
cage without a cover for recording. Corn cob bedding (Envigo, Madison, WI) was used to 
line to bottom of the cage. Two to three pieces of dry chow and a water bottle were 
placed in the cage. 
3.8 Data Acquisition and Analysis 
3.8.1 Key Sensor Parameters from Beaker Experiments 
The Fast analysis® software provided by Quanteon was used for data analysis. 
Sensitivity was defined as the change in current for each unit of analyte addition. 
Sensitivity was calculated from the slope (pA/μM) of the calibration curves (current 
density vs concentration curves). Then the slope was converted into nAμM-1cm-2 by 
dividing it by the Pt microelectrode area (5 × 10-5 cm2 in case of 8-TRK probes and    
1.27 ×10-4cm2 in case of microwire channels). The limit of detection (LOD) was 
calculated by dividing (3 times the standard deviation of 10 points from the baseline) by 
the least squares slope, which is based on the FAST 2014 software manual provided by 
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Quanteon. The baseline is the signal that was obtained when no electroactive analyte was 
present in the solution. 
3.8.2 Data Storage for ex-vivo and in-vivo Recordings 
For ex-vivo and in-vivo recordings the FAST system was set to acquire current 
data at 1000 Hz (biased at +0.7 V). An entire data file is too large for traditional software, 
such as Microsoft Excel. Therefore, we used the Fast Analysis software which is 
integrated into the FAST recording system to store time and current data in 1000 s 
segments as csv files for offline analysis. 
3.8.3 Definitions and Determination of Key Peak Parameters 
Current data were imported into ORIGIN-PRO 2019B for analysis.  Individual 
responses were isolated based on noted stimulation times. The current from interferents 
on the sentinel channel was subtracted from the GLU channel to derive the current due to 
GLU. An example plot is shown in with the raw signals for GLU and the sentinel 
channels in Panel A and the subtracted GLU signal (IGLU – ISentinel) in Panel B. Similarly, 
the current from interferents on the sentinel channel and signal in the GLU channel   was 
subtracted from the GABA channel to derive the current due to GABA. An example plot 
is shown in Figure 3-5 with the raw signals for GABA channels in Panel A and the 
subtracted GLU signal and sentinel signal (IGABA – (IGLU- ISentinel) in Panel B. Response 
current was allowed to return to baseline before each subsequent stimulation; the mean of 
the last 10 s of each response was used to define that response’s baseline.  Maximum, 
10%, 50%, and 90% values of the peak response were then determined as shown in 
Figure 3-5. The time between 10% and 90% of the rising peak were used to determine the 
rise time (TR). Squares in Figure 3-5; A&B shows the peak of each signal. 
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Figure 3-5: Sample plot of current response to electrical stimulation. A. Raw current 
recorded from the GABA, GLU and sentinel channels. B. Resulting GLU and GABA 
signal after the relevant subtraction are done. C. Shows Rise time (TR10-90, time 
between blue squares), decay time (TD10-90, time between red squares) and full 






The time between 90% and 10% of the falling peak were used to calculate the 
decay time (TD). The time between the rise and fall of the peak at 50% of the maximum 
current was used to measure the full width and half maximum (FDHM). Responses were 
discarded if features were indistinguishable from noise (< 2X noise) or if the sentinel 
signal increased above the GLU channel. GABA current was obtained by subtraction of 
both the sentinel and GLU channel current. Peak values were converted into µM 
concentration based on calibration curves. 
3.9 Thickness Measurement 
Keyence 3D Laser Scanning Confocal Microscope (model VKX150, Keyence, 
Osaka, Japan) was used for thickness measurement. Using the accompanying visual 
software VKViewer we measured the average roughness in the electrode area where there 
was enzyme coating. We subtracted this roughness from the average roughness without 
the enzyme coating. The result is our enzyme coating thickness. Thicknesses were 
measured and averaged from three sets of data (n=3).  
3.10 Statistics 
Error value is shown as mean ± SEM. Two-tailed Students t-test was performed at 
95%confidence interval (p<0.05) to compare means. One-way ANOVA was performed 
with significance defined as p < 0.05 to verify if sensor-to sensor variation (in the same 
site) is significant. All other normally distributed data were analyzed using ANOVA, 
with significance at α = 0.05. For the ex-vivo and in-vivo data, evaluation of peak 
concentration values indicated that they were not normally distributed, and the 
independent Wilcoxon test was used to determine significant effects for α = 0.001, α = 








4.1 Surface Cleaning 
First part of our development of the GABA sensor is to clean the 8-TRK 
microelectrode surface. When we receive the microelectrodes from the manufacturer, the 
surface may have some dust particles or unwanted surface deformities. To remove those, 
we need to clean the surface. One other aspect of these dust particles is that, they may 
reduce the sensitivity of microelectrodes (sensors).  One good way to track the surface 
conditions is to calibrate hydrogen peroxide (H2O2) in the microelectrodes. As H2O2 is 
also our reporter molecule (responsible for the current) the increased sensitivity towards 
H2O2 also means our surface will be more responsive towards GABA/GLU.  
In our studies we have cleaned the surface with methanol first and then 
electrochemically with mild sulfuric acid. After each step we calibrated the sensors for 1-
5 μM H2O2 (n=4). The as-received microelectrodes have a sensitivity of 1680± 102 
nA/µMcm2 . However, after methanol cleaning this number increased to 1900 ± 110 
nA/µMcm2 . This corresponds to almost 15% increase from our initial sensitivity. Further 
electrochemical cleaning in 0.05 M sulfuric acid (cyclic voltammetry, [−0.3 V, +1.0 V], 
20 mV/s, and 15 cycles) in a 2-electrode setup using a saturated calomel electrode as the 
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RE, shows more increase in our sensitivity. The sensitivity after CV cleaning is: 3180 ± 
134 nA/µMcm2. We show these results in Figure 4-1. 
 
Figure 4-1: Comparison of cleaning methods. H2O2 calibration for as-received(black); 
with methanol clean (red) and methanol +echem cleaning (blue).  Amperometry 
parameters:  + 0.7 V vs Ag/AgCl wire in 1X PBS beaker in room temperature; the 
solution was always stirred at 200 rpm 
As the results show we get almost 90% increases in our H2O2 sensitivity after this 
two-part cleaning.  The reason for can be attributed to increased porosity and surface 
roughness due to electrochemical treatment.  One more reason for this behavior can be 
found in the works of Chao et.al.,who show, by electro-impedence-spectroscopy (EIS), 
that with CV cleaning, charge transfer resistance reduces and electron transfer between 
the electrode and electrolyte happens more rapidly. From their experiments they also 
found that, CV cycling completely etches off grain boundaries which in turn make the 
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grains more conducive than grain boundaries. The etched grain boundaries may also be 
the cause of atomic scale heterogeneity [90]. 
4.2 GABA Calibration in α-ketoglutarate 
Studies have shown dependence of the GABA current response (pA) on 
concentration of α-ketoglutarate [11], which is an important molecule in physiological 
functions, for example in the Krebs cycle[99]. Therefore, we first studied the 
electrochemical response of the Glu and GABA microbiosensors (Sites 1 and 2) in the 
presence of different amounts of α-ketoglutarate (1 µM – 500 µM) in the solution. Figure 
4-2 shows the typical AM responses at Sites 1 and 2 in 1X PBS supporting electrolyte 
(background or control, blue dashed, red dashed curves), and to varying concentrations of 
GABA (5, 10, 20 and 40 µM) in 100 µM α-ketoglutarate solution prepared in 1X PBS 
(blue solid, red solid curves).These values of concentration in the micromolar range. 
They were chosen because of their relevance to the ones encountered in the brain 
microenvironment where GABA is typically present [26].For example, GABA levels are 
in the range of 20-70µM in rat brain slices, [28],and up to 1.25 µM/cm3in the human 
brain[29]as measured by proton magnetic resonance spectroscopy. The response was 
recorded in different concentrations of α-ketoglutarate solution, first by allowing the 
microbiosensors to stabilize in the solution for up to 240 s, and then injecting GABA at 1 
min time intervals to obtain the desirable concentration Figure 4-2. From Figure 4-2, as 
expected, we observe that the GLU microbiosensor at Site 1 did not exhibit a response to 
GABA because of the absence of the GABASE enzyme. Also, there was no enzymatic 
activity of GOx in converting GABA into Glu and then into H2O2. This indicates that the 
GABA conversion is highly selective at Site 2 that has GABASE and not at Site 1. The 
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GABA microbiosensor at Site 2 responded to GABA when the α-ketoglutarate 
concentration was at least 40 µM (Figure 4-2). 
 
Figure 4-2: GABA probe calibration (5-40 μM GABA) in different concentrations of 
α-ketoglutarate (5, 10, 20, 40, 100, 200, and 500 μM) in 1X PBS. A. Current response 
at GABA microbiosensor in Site 2 and Glu microbiosensor in Site 1 in PBS only 
(background or control – red dashed curve, blue dashed curve, respectively) and in 
100 μM α-ketoglutarate in 1X PBS (red and blue solid curves, respectively). B. 
Current response at GABA microbiosensor for other concentrations of α-
ketoglutarate. The lower concentration at which there was no GABA response is 
shown in dotted lines. GABA responses of 40,200 and 500 μM are shown in red, 
green and blue. The microbiosensors were biased at + 0.7 V vs Ag/AgCl reference. 
The solution was stirred at 200 rpm and maintained at 37°C [14]. 
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A transient spike in the signal was observed during the injection of the 
solution in the beaker. However, the signal was stabilized a few seconds following the 
injection of the solution. Sometimes the time to stabilization was a bit longer (e.g. in 
the case of 40 μM and 500 μM α-ketoglutarate experiments). This might be due to a 
few bubbles in the micro syringe pump that disturb the solution, more in certain 
experiments than others. The other data points for the same α-ketoglutarate 
concentrations did not show similar spikes. The highest sensitivity was observed at 
100 µM. From Figure 4-3, the sensitivity is36±2.5 pA µM-1 cm-2 and the LOD is 
2±0.12μM(N=6), which is 10-fold higher than that of similar amperometry-based 
microsensors[11].The sensitivities at 40 μM,200 μM and 500 μM of α-ketoglutarate 
were 12±1.7, 20±2.4 and 28±2.5 respectively, and the LOD was 7±0.7, 4.0±0.4 and 
3±0.24, respectively (Table 4-1). This GABA response to α-ketoglutarate 
concentration is in agreement with previously published literature [11].  
One possible reason for the decrease of GABA sensitivity at highest α-
ketoglutarate concentrations could be due to their scavenging of H2O2 as suggested by 
previous studies [100], [101]. Another study [26] showed a similar trend where the 
GABA sensitivity was highest at 1mM α-ketoglutarate and then decreased at much 
higher concentrations. The LOD achieved using the non-optimal GABA 
microbiosensor is 2-7 μM, which is lower than the clinically-relevant concentrations 





Figure 4-3: Current response and linear fitting at GABA microbiosensor for 
different GABA concentrations and α-ketoglutarate concentrations at ≥ 40 μM. A. 
shows the currents in bar-charts. B. Shows the linear fit. Linear fit parameters 
obtained: 40 μM α-keto sensitivity = (12 ± 1.5 nA/μMcm2), R2 = 0.99728; 100 μM 
α-keto sensitivity = (36 ± 3 nA/μMcm2), R2 = 0.99582; 200 μM α-keto sensitivity 
= (20 ± 2.6 nA/μMcm2), R2 = 0.99582 and 500 μM α-keto sensitivity = (28 ± 2.8 
nA/μMcm2); R2 = 0.99582 at GABA microbiosensor. Legends: 40 μM (red), 100 
μM (green), 200 μM (blue) and 500 μM (magenta).  Error bars are shown as 




Sensitivities differ slightly between microelectrodes, which are likely due to 
variations in the quantity of enzymes that are manually applied to each site.  Any 
potential defects in the surface of the electrodes may also lead to a difference in 
sensitivity. But this could be remedied by employing an array of GABA and Glu 
microbiosensors and by applying appropriate statistics (e.g. averaging the current values 
etc.). This sensitivity variation can be further minimized by employing micro spotting 
techniques that are fully automated and dispense very precise volumes of enzyme 
solutions. 
Table 4-1: GABA sensitivity and LOD for different  α-ketoglutarate concentration [14] 
α-ketoglurate 
concentration (µM) 
Sensitivity (nA μM-1cm-2) LOD (µM) 
40 12±1.7 7±0.7 
100 36±2.5 2±0.12 
200 20±2.4 4±0.4 
500 28±2.5 3±0.24 
40 12±1.7 7±0.7 
 
4.3 Effect of Enzyme Concentration 
Sensitivity is the most key factor when designing any kind of sensors. In our case 
we have two neurochemicals GABA and GLU. We want to design a sensor that gives 
highest sensitivity to both GABA and GLU. For these experiments we use different 
concentrations of GOx (0.1, 0.2, 0.3, 0.4, 0.6 and 0.8 unit/μL) and different 
concentrations of GABASE (0.05, 0.1, 0.2, 0.3, 0.4 and 0.8 unit/μL). We modify our 
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GABA electrode with certain combinations (ratio) of these enzymes. However, the GLU 
electrode we modify with only GOx.  We did a calibration of 20-60 μM GABA and 20-
60 μM GLU to check for the sensitivity of both GABA and GLU. 
For our first experiments, we observe the responses with increasing GABASE 
concentrations, keeping the GOx constant. The GLU electrodes in these cases have the 
same GOx concentration. We see that, the GABA response is highest when GABASE 
concentration is 0.1 unit/μL and the GABA responses decreases with increasing 
GABASE concentrations. Meanwhile, the GLU responses remain somewhat similar 
across GABA and GLU electrodes. Although, when the GABASE concentration 
increases (e.g. 0.8 GABASE+0.1 GOx) the signal quality worsens. We show these results 
in Figure 4-4.  
In the next step we do the reverse experiments. We observe signals with 
increasing GOx concentrations keeping the GABASE concentration constant. In these 
cases, GOx concentrations increase in the GLU electrodes. We see that, for both GABA 




Figure 4-4: The comparison of GABA and GLU sensitivities. A. Shows GABA and 
GLU calibration in GABA electrode. B. Shows the GABA and GLU calibration GLU 
electrode. These experiments were done in 100 μM α-ketoglutarate+1X PBS. The 
microbiosensors were biased at + 0.7 V vs Ag/AgCl reference. The solution was 
stirred at 200 rpm and maintained at 37°C. Legends: 0.05 GABASE+0.1 GOx (black); 
0.1 GABASE+0.1 GOx (red); 0.2 GABASE+0.1 GOx (blue); 0.3 GABASE+0.1 GOx 





Figure 4-5: GABA and GLU signals in different conditions. A. Shows GABA and 
GLU signal when GABASE concentration is kept constant and GOx concentration 
increases in GABA electrode.  Legends: 0.1 GABASE+0.1 GOx (black); 0.1 
GABASE+0.2GOx (red); 0.1 GABASE+0.3 GOx (blue); 0.1 GABASE+0.4 GOx 
(green); 0.1 GABASE+0.6 GOx (orange); 0.1 GABASE+0.8 GOx (violet). B. shows 
the GABA and GLU signal in GLU electrode with increasing GOx concentration. 
Legends: 0.1 GOx (black); 0.2 GOx (red); 0.3 GOx (blue); 0.4 GOx (green); 0.6 
GOx(orange); 0.8 GOx (violet). These experiments were done in 100 μM α-
ketoglutarate+1X PBS. The microbiosensors were biased at + 0.7 V vs Ag/AgCl 
reference. The solution was stirred at 200 rpm and maintained at 37°C. 
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The highest GLU sensitivity is at 0.4 unit/μL and GLU sensitivity decreases after 
that point. The GABA response, however, remains somewhat similar; even though signal 
quality decreases. The GLU and GABA sensitivity in terms of enzyme concentration can 
be seen in Figure 4-4, Figure 4-5 and Figure 4-6. It can be explained with Michaelis-
Menten theory (APPENDIX A). It states that, reaction rate (in our sensitivity) depends on 
enzyme concentration. The signal is  maximized at the transition point of diffusion 
limitation and kinetic limitation [32]. It is understandable that for a certain enzyme a 
certain concentration will give highest sensitivity. In our studies the GABA signal is 
highest when GABASE concentration is 0.1unit/μL and GLU response is highest when 
GOx concentration is 0.4 unit/μL. High (more than the optimal) enzyme concentration 
can lead to low solubility and high viscosity of enzyme aliquots [32]. This leads to 
thicker enzyme membrane layer and thus limits the diffusion of analyte in the enzyme 
membrane [32]. In higher enzyme concentration, both GABASE and GOx, the signals 
become noisy because the enzyme layer becomes diffusion-limiting (see APPENDIX B 
for all the sensitivity values). 
In literature they have used GABASE concentration of 0.0125 unit/μL in similar 
electrode geometry[15]. The sensitivity in that case was 40±8 nA/μMcm2 [15]. In our 
studies we got the highest GABA sensitivity at 84±11nA/μMcm2 which is almost 2 times 
the literature. Appendix-B shows the GABA and GLU sensitivity in all enzyme 
concentrations. For our subsequent experiments we use the concentration of 0.1 unit/μL 
GABASE and 0.1 unit/μLGOx in the GABA electrode because it gives the highest 
GABA sensitivity and acceptable GLU sensitivity. In the GLU electrode we keep 0.1 
unit/μLGOx constant.  
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Figure 4-6: A. Shows the GABA sensitivity with increasing GABASE concentration. 
GOx concentration is 0.1unit/μL. B. Shows the GLU sensitivity with increasing GOx 




4.4 Effect of Enzyme Loading (thickness) 
The next experiments we performed were to study the enzyme loading/thickness 
on the platinum surface. With each drop our enzyme layer thickness increases. 
Thicknesses were measured and averaged from six sets of data (n=6) using a Keyence 3D 
Laser Scanning Confocal Microscope (model VKX150, Keyence, Osaka, Japan). 
Wechange number of drops from 1 to 8 in the platinum surface and observed the 
response. We did a calibration of 20-60 μM GABA and 20-60 μM GLU to check for the 
sensitivity of both GABA and GLU in both the electrodes. We observed with the 
increasing number of drops the thickness of the enzyme increases in both the GABA and 
GLU electrode surfaces. shows the thickness of both the GABA and GLU electrode 
surfaces. 
Table 4-2: Thickness variation with # of drops 
# of drops Thickness of GABA 
electrode site (μm) 
Thickness of GLU 
electrode site (μm) 
1 drop 0.49±0.03 0.38±0.05 
2 drops 0.89±0.07 0.81±0.06 
3 drops 1.41±0.32 1.39±0.25 
4 drops 2.13±0.74 2.06±0.56 






In site-1(GLU sensors) we can only observe current for GLU as shown in Figure 
4-7. Injection of GABA in these sites has no effect on the current. As there is no 
GABASE, GABA can’t react with α-ketoglutarate and subsequently produce H2O2. 
However, in site-2 we observe sensitivity for both GABA and GLU because of the 
presence of both GABASE and GOx as shown in Figure 4-7.  
In case of the GABA electrode we observe the sensitivity for GABA is 138±21 
nA/μMcm2 when we have only one drop of enzyme but the sensitivity decreases to 
76±13nA/μMcm2 if we have 4 drops of enzyme. This is almost 70% decrease sensitivity. 
This is shown in Figure 4-8. 
Similar trend is observed for GLU sensitivity in both the GABA and GLU 
electrode. For GABA electrode the GLU sensitivity decreases from 297±42 nA/μMcm2 to 
179±42 nA/μMcm2 when we increase the number of drops from 1 to 4. This is a decrease 
of 65%. Similarly, for GLU electrode the GLU sensitivity decreases from 267±40 
nA/μMcm2 to 152±22 nA/μMcm2 when we increase the number of drops from 1 to 4. 
This is a decrease of 75%. This is shown in Figure 4-8. 
The reason for this trend can be found in the diffusing mechanism of the enzyme 
layer. When the enzyme is layer is thin the molecules can diffuse freely into the layers 
and react with them but if the layer is thick then the molecule cannot diffuse easily. Thus, 
results in less sensitivity. Previous works have explained this phenomenon by doing the 
H2O2 calibration in different thickness of enzymes [102]. They found that if the enzyme 
layer is thick the H2O2 sensitivity will be low too. That can explain our decreasing 
sensitivity with thicker enzyme layer. 
58 
 
Figure 4-7: GABA and GLU signals in different enzyme thickness (#of drops) 
A.Shows GABA and GLU signals when in GLU electrode coated with 0.1 
unit/μLGOx . B. Shows the GABA and GLU signal in GABA electrode coated with 
0.1 unit/μLGABASE and 0.1 unit/μLGOx. These experiments were done in 100 μM 
α-ketoglutarate+1X PBS. The microbiosensors were biased at + 0.7 V vs Ag/AgCl 
reference. The solution was stirred at 200 rpm and maintained at 37°C. Legends: 1 




Figure 4-8: GABA and GLU sensitivity for both the electrodes. A. Shows the GABA 
sensitivity of the GABA electrode (blue bars). B. Shows the GLU sensitivity GABA 
electrode (green bars) and   GLU sensitivity GLU electrode (red bars). Error bars are 




4.5 Effect of pH 
Solution pH plays an important role in any kind of enzymatic sensors. Moreover, 
each enzyme has different “working pH”, pH at which the enzyme is most reactive. Since 
we used two enzymes to modify the electrode surface, we had to examine at which pH 
the enzymes work best. In our normal lab condition 1X PBS always has a pH of 7 (6.95-
7.1). To get pH=5 we make the solution acidic with 1×10-5M HClO4. We start off with 
0.1M HClO4 and reach our desired concentration after a series of dilutions. To get pH=11 
and pH=9 we make solution alkaline with 1×10-3M and 1×10-5M KOH respectively. In 
this case too we start off with 0.1M KOH and reach our desired concentration after a 
series of dilutions. We did a calibration of 20-60 μM GABA and 20-60 μM GLU to 
check for the sensitivity of both GABA and GLU in both the electrodes. 
As expected, the GLU electrodes don’t respond to GABA but responds to GLU 
whereas GABA electrodes respond to both GABA and GLU. This is shown Figure 4-9. 
In case of GABA sensitivity in GABA electrode, we see that GABA sensitivity is highest 
at pH=9, 72±11 nA/μMcm2 and lowest at pH=11, 20 ±6 nA/μMcm2. This is shown in 
Figure 4-10. In contrast, GLU sensitivity is highest at pH=7 in both the GABA electrode, 
156±22 nA/μMcm2 and in GLU electrode, 104±20 nA/μMcm2. However, GLU 
sensitivity is lowest at pH=11 in both the GABA electrode, 36±6 nA/μMcm2 and in GLU 
electrode, 28±4 nA/μMcm2.  These results are shown in Figure 4-10.  The low 
sensitivities of GABA and GLU in pH=11 can be attributed to the extreme alkalinity of 
the solution.  
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Figure 4-9: GABA and GLU signals in pH conditions A. Shows GABA and GLU 
signals when in GLU electrode coated with 0.1 unit/μLGOx . B. Shows the GABA 
and GLU signal in GABA electrode coated 0.1 unit/μL GABASE and 0.1 
unit/μLGOx.  These experiments were done in 100 μM α-ketoglutarate+1X PBS. The 
microbiosensors were biased at + 0.7 V vs Ag/AgCl reference. The solution was 
stirred at 200 rpm and maintained at 37°C. Legends: pH=5 (black), pH=7 (red), pH=9 






Figure 4-10: GABA and GLU sensitivity for both the electrodes. A. Shows GABA 
sensitivity of the GABA electrode (blue bars). B. Shows the GLU sensitivity GABA 
electrode (green bars) and   GLU sensitivity GLU electrode (red bars). Error bars are 





These results can be explained by the inherent qualities of the enzymes. 
According to manufacturer label and prior literature optimum GABASE condition is  
pH=8.6 [15]. This may be the reason why GABA sensitivity is highest at that pH. We 
note that GABA is a neutral molecule so the GABA sensitivity is assumed to be 
dependent upon GABASE and α-ketoglutarate as discussed in earlier sections. On the 
otherhand the GLU sensitivity is highest at pH=7 because this is the GOx optimum 
condition. It is highly likely that in various tissue and live brain conditions we will come 
across pH conditions that are not neutral, pH=5. In those cases, we can use these results 
to interpolate the GABA and GLU sensitivity in different ex-vivo/in-vivo pH conditions. 
4.6 Linear Range Determination 
To determine the linear range of the GABA sensors, we generated the plots for 5-
500 μM GABA concentrations versus different α-ketoglutarate concentrations. We 
observe that the GABA current values saturate, and saturation depends on the α-
ketoglutarate concentration as shown in Figure 4-11. For example, at 40 μM α-
ketoglutarate, the GABA signal saturation is at 50 μM shown in Figure 4-12, whereas in 
100, 200 and 500 μM α-ketoglutarate concentrations, the GABA signal saturation occurs 
at 100 μM as shown in Figure 4-12.The trend in sensitivity in the linear range is the same 
as before. For 100 μM α-ketoglutarate, the GABA sensitivity is highest and decreases at 
other concentrations of α-ketoglutarate. The linear range for GABA also depends on the 
α-ketoglutarate concentration. For 40 μM α-ketoglutarate, the GABA signal is linear upto 
50μM shown in ( Figure 4-12:inset) for other concentration the GABA signal is linear 
upto 100 μM shown in Figure 4-12 (inset). 
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Figure 4-11: Calibration of GABA (5-500 µM GABA) in the presence of different 
concentrations of α-ketoglutarate in site 2 (GABA microbiosensor). Legends: Current 
response at GABA microbiosensor in Site-2 in 100 μM α-ketoglutarate (green curve), 
40 μM α-ketoglutarate (red curve), 200 μM α-ketoglutarate (blue curve) and 500 μM 
α-ketoglutarate (magenta curve). GABA electrode coated 0.1unit/μLGABASE and 
0.1unit/μLGOx [14]. * α-keto= α-ketoglutarate 
 
This phenomenon can be explained by Michaelis-Menten theory (see APPENDIX 
A). It states that, enzyme-based reactions remain linear until the reaction rate reaches half 
its maximum value (Vmax/2).  The concentration at which the maximum reaction rate is 
half the maximum value, is called Km. In all our calibration curves we have shown the 
Vmax/2 and Km (Figure 4-12). Km value represents the concentration where our current is 
linear. Usually after the Km value the current increases non-linearly or saturates (no 
current increase with increasing concentration. As expected in our Km value is dependent 
on the α-ketoglutarate concentration. The Km value for 40,100,200 and 500 μM α-
ketoglutarate is 50,100,100 and 100 μM GABA respectively.  
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Figure 4-12: Current response of GABA (5-500 µM GABA) at different α-
ketoglutarate concentrations and the linear range. A. Current response of GABA at 40 
µM α-ketoglutarate (red dots). B. Linear range up to 50 µM GABA (solid line). 
Linear fit parameters GABA sensitivity: 14±1 nA/μMcm2, R2=0.99486. 
C. Current response of GABA at 100 µM (green dots), 200 µM (blue dots) and 500 
µM (magenta dots) α-ketoglutarate. D. Linear range up to 100 µM GABA for all α-
ketoglutarate (solid black line) concentration. Linear fit parameters GABA sensitivity 
in 200 µM α-ketoglutarate: 32±4 nA/μMcm2, R2=0.99692. Linear fit parameters 
GABA sensitivity in 500 µM α-ketoglutarate: 47±10 nA/μMcm2, R2=0.9982. Linear 
fit parameters GABA sensitivity in 100 µM α-ketoglutarate: 61±14 nA/μMcm2, 
R2=0.99692 [14]. *α-KG= α-ketoglutarate 
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4.7 Effect of Size-Exclusion Layer 
Selectivity is a key characteristic of any kind of sensor. This is especially true 
for neurochemical sensors. Since the eventual goal of our neurochemical sensor is to 
implant this sensor in-vivo or ex-vivo where a lot of interferents are present, our sensor 
must be selective to GABA (and GLU). A platinum surface without any selective 
layer will oxidize all the interferents like Ascorbic Acid (AA), Dopamine (DA) which 
are electroactive species that could contribute to faradaic signal if they are present in 
the solution. We observe similar signals in our electrode surfaces too as shown in 
Figure 4-13. As expected GLU electrode doesn’t react to GABA but reacts to all other 
chemicals. GABA electrode shows response to all neurochemicals as shown in Figure 
4-13.  Cellulose acetate or polyphenol is commonly used as size exclusion layer. The 
main principle behind is that, this layer blocks large intereferent molecules while still 
allowing penetration of smaller molecules like H2O2. These size exclusion layer 
works on the basis of electrostatic repulsion between ions. For example, nafion is a 
negatively charged polymer that can block negatively charged ascorbate ions.  
For this study we used 1,3-phenylenediamine (mPD) as our perm-selective 
layer. We selected mPD because mPD is a well know polymer to be used as a perm-
selective layer [12]. In this work 10 mM mPD was prepared in 1 M NaCl and then 
purged with nitrogen for 30 min. Cyclic voltammetry scans between +0.2 V and +0.8 
V, using a saturated calomel electrode as a reference electrode, were performed to 
form a size-exclusive mPD layer. In later sections we discuss two different scan rates 
for coating and their effects on the selectivity and sensitivity. These mPD coated 
MEAs were rinsed with DI water and stored for use. 
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Figure 4-13: A. shows the signals for all chemicals in both GABA (red curve) and 
GLU electrode (black line). B. Shows the zoomed in version of the signal in blue 
circle (100-700 sec range; Legends: Ach= acetylcholine, Ch=choline, 5-







As we can see from above, all molecules oxidize in the electrode surfaces 
producing current. The current is especially high in case of AA. In the brain AA is 
ubiquitous. To improve that problem we coat the surface with mPD using two different 
scan rates 50 mV/s and 5mV/s. As expected, we see signal from interferents (especially 
AA) decreased rapidly. This is shown in Figure 4-14. A zoomed in version of this can 
also be seen in Figure 4-15. However, we observe from Figure 4-15 that, both the GABA 
and GLU sensitivity decreases when we have the selective layer. The sensitivity for 
GABA decreases 40% in case of 50 mV/s scan rate and decreases 53% in case of scan 
rate 5 mV/s. The sensitivity and selectivity values for all neurochemicals are summarized 
in Table 4-3.  
 
Figure 4-14: Interferent rejection signals for chemicals in GABA electrode. We show 
the signals when the electrode had no exclusion layer (black curve), the scan rate for 
the selective coating was 50 mV/s (red curve) and the the scan rate for the selective 
coating was 5 mV/s (blue curve) in GABA electrode coated 0.1 unit/μL GABASE and 
0.1 unit/μLGOx. The solution had 100 µM of α-ketoglutarate. The microbiosensors 
were biased at +0.7 V vs Ag/AgCl reference. The solution was stirred at 200 rpm and 
maintained at 37° C.  mPD coating uses CV [+0.2 to +0.8 V] 
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Figure 4-15: Shows the detailed versions of Figure 4-14. The experimental 
conditions remained the same. We show the 200-700 sec range. We show the 
signals when the electrode had no exclusion layer (black curve), the scan rate for 
the selective coating was 50 mV/s (red curve) and the the scan rate for the 
selective coating was 5 mV/s (blue curve) in GABA electrode coated 0.1 unit/μL 
GABASE and 0.1 unit/μL. mPD coating uses CV [0.2, 0.8 V]. 
*Ach= acetylcholine, Ch=choline, 5-HT=serotonin, DA=dopamine, UA=Uric 
acid, AA=Ascorbic acid. 
The decrease in sensitivity in different scan rates can be attributed to the 
thickness difference in the surface. Thickness was measured using the confocal 
microscope (VK X-100, Keyence Company, Osaka, Japan). We observe if we coat 
at 50 mV/s the thickness is 26±5 nm. In contrast if we coat at 50 mV/s the 
thickness is 71±5 nm. This changing thickness can also be verified by observing 
the H2O2 sensitivity. The H2O2 sensitivity in 50 mV/s scan rate is 780±56 
nA/μMcm2. However, The H2O2 sensitivity in 5 mV/s scan rate is 420±67 
nA/μMcm2. This contrast in sensitivity suggests that thicker layer block more 
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H2O2 and results in lower sensitivity. In case of 5mV/s, the signals are noisier, than 
50 mV/s signal. This is due to the thicker layer and diffusion limiting mechanism. 
Table 4-3: Effect of mPD in GABA and GLU sensitivity (nA/ μMcm2) [second 
and third column] and acetylcholine (Ach.), choline (Ch.) and serotonin (5-HT) 
selectivity against GABA (no unit)  [third, fourth and fifth column] 
Conditions GABA GLU Ach Ch. 5-HT 
No mPD 65±13 708 ±79 11.3±2 11.3±3 1±0.5 
Scan rate 50 
mV/s 
40 ±7 381±53 ∞ ∞ ∞ 
Scan rate 5 
mV/s 
28 ±11 223±31 ∞ ∞ ∞ 
 
We see from Table 4-3 that, the sensitivity for GABA and GLU decreases 
with high scan rates. Even though the sensitivity decreases we know from previous 
studies [90]  that thicker layer of mPD lasts longer. We see from Table 4-4 that, 
the selectivity for AA increases with high scan rates. According to literature AA 
selectivity value of 35 is acceptable [15]. Our GLU selectivity is 189±32 and 








Table 4-4: Effect of mPD on dopamine (DA), uric acid (UA), ascorbic acid (AA) 
and H2O2 selectivity against GABA (no unit)  
Conditions DA UA AA H2O2 
No mPD 0.2±0.05 1.5±0.03 0.03±0.01 0.2±0.001 
Scan rate 
50mV/s 
∞ ∞ 57±14 0.3±0.002 
Scan rate  
5mV/s 
∞ ∞ 85±12 0.5±0.008 
 
  
4.8 GABA Calibration in Presence of Glutamate 
The GABA probe was calibrated in the presence of (5-80 μM) range of 
concentrations of GLU, which mimics the brain microenvironment both in healthy and 
diseased states. For example, the basal concentration of GLU in the extracellular space is 
up to 20 μM[103], while GLU concentrations in cerebrospinal fluid are∼10 μM. During 
seizures, GLU levels increase 4-fold and GABA levels decreases [104]–[106].GLU is a 
major excitatory neurochemical that is ubiquitously present as L-glutamate in its anionic 
form (glutamic acid) in the brain environment (henceforth called GLUE)[103].One of the 
objectives of this study was to monitor GLUE as an in-situ source for the generation of α-
ketoglutarate, which aids in the continuous real-time GABA monitoring at Site 2, and 
thus does not rely on the addition of α-ketoglutarate externally. Firstly, we calibrated the 
two microbiosensors by injecting GLU at various concentrations (5 µM, 10 µM, 20 µM, 
40 µM and 80 μM) in 1X PBS buffer solution. Figure 4-16 shows the response of the two 
microbiosensors. The GABA microbiosensor (Site 2) consistently exhibited a slightly 
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higher GLU response than that of the GLU microbiosensor (Site 1). The GLU sensitivity 
of Site 2 and Site 1 are 132±10 nAμM-1cm-2 and 94±5 nAμM-1cm-2, respectively. The 
difference in the current response from the two microbiosensors increases with higher 
GLU concentrations (Figure 4-16). To further understand this, we modified Site 2 with 
only GABASE and no GOx. Ideally, there should not be any response from the GABA 
microbiosensor. However, a small response was observed (Figure 4-16). This confirms 
our hypothesis that some non-selective activity of GABASE is due to GLU oxidation. 
Others have made similar observations where GABASE showed weak enzyme activity 
towards Glu compared to GOx [11]. 
The large response could also be due to the presence of more enzymes per unit 
volume (0.2 U/μl) that somehow collectively create more active sites [107].To account 
for this difference in the Glu response, henceforth called the background noise, Ib (shown 
in Figure 4-16), the Ib has to be subtracted from the difference in the currents (IGABA) at 
the two sites  to obtain the final current response to GABA (details discussed later). 
The next calibration step was to experiment with different GABA solutions (0, 5, 
10, 20 µM) in 1X PBS buffer and repeat the above GLU calibration (Figure 4-17). These 
experiments were performed without adding α-ketoglutarate externally. At Site 1, GluE is 
oxidized to α-ketoglutarate and H2O2 (E) (reaction 2, shown in Chapter-2). This α-
ketoglutarate then reacts with GABA at Site 2 and produces GLUGABA (reaction 1, shown 
in Chapter-2) followed by reaction 4 (shown in Chapter-2), which generates H2O2(GABA) 
and more α-ketoglutarate. These reactions and pathways were shown in earlier chapter. 
At the GABA microbiosensor (Site 2), in the case of no GABA in the solution, the 
current response (H2O2 (Site 2)) is due only to the changing GLU levels in the solution 
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(Figure 4-17, red curve). When GABA is present in the solution, the H2O2 (Site 2) response 
is from both GABA and GLU oxidation and we expect it to be larger than the response 
when there was no GABA. Therefore, higher GABA concentrations appear to induce a 
greater response (Figure 4-17, blue, green, magenta curves) at Site 2 and greater IGABA, 
which is the GABA signal as shown in Chapter-2, shows the sensitivity of the GABA 
microbiosensor at different GABA and GLU concentrations.  
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Figure 4-16: A. Current response at GABA microbiosensor in Site 2 and Glu 
microbiosensor in Site 1 (red and blue solid curves, respectively). Arrows indicate 
GLU infusion. B. Inset showing the linear fitting for GABA and Glu microbiosensors 
(red and blue dotted lines) C. The difference in the current response between the 
microbiosensors (blue bars). The current response at GABA microbiosensor (that was 
coated with GABASE enzyme only; no GOx enzyme) (red bars). No α-ketoglutarate 
added during all the experiments [14]. 
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With increasing GABA and Glu concentrations, the sensitivity of the GABA 
microbiosensor increases and this is because of increased availability of α-ketoglutarate. 
The sensitivity and the LOD of the two microbiosensors are shown in Table 4-5 and 
Table 4-6. The GABA sensitivity increased by ∼25% at 20μM GABA concentrations. 
The sensitivity reported here is greater than that of the Pt based GLU sensors published in 
the literature [108] The LOD is comparable to other Glu sensors [109].  
Table 4-5: Sensitivity(SS, nA.µMcm2) of GLU (SSGLU) and GABA (SSGABA) sites 
GABA concentration SSGLU SSGABA 
0 94±5 132±10 
5 101±8 148±7 
10 100±10 156±8 
20 102±12 168±21 
 
The difference in current, shown in Figure 1-17, is caused by the presence of 
GABA in the solution. The GABA signal was quantified as IGABA = H2O2 (Site-1)− 
H2O2(Site2). The IGABA is plotted for varying GABA and GLU concentrations Figure 4-18 
after subtracting the Ib noise. 
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Table 4-6: Limit of detection (LOD, µM ) of GLU (LODGLU) and GABA (LODGABA) 
sites 
GABA concentration LODGLU LODGABA 
0 0.23±0.01 0.08±0.007 
5 0.22±0.01 0.07±0.008 
10 0.23±0.02 0.07±0.009 
20 0.23±0.01 0.08±0.007 
 
The positive values for IGABA at all concentrations of GABA and GLU confirm 
GABA detection at Site 2. As expected, the IGABA increases as GABA concentrations 
increase. The GABA calibration curves, following linear approximation of IGABA at 
various GLU concentrations, is shown in Figure 4-18. A steeper slope is evident at 
higher GABA concentrations. Values of the slope are 42±4 nAμM-1cm-2, 49±6 nAμM-
1cm-2 and 70±11 nAμM-1cm-2 for 5 µM, 10 µM and 20 µM GABA, respectively.  
To better understand the GABA signal dependence on GLU concentrations, 
IGABA values were plotted in terms of different molarity ratios of GABA:GLU (1:1, 1:2, 
1:4 and 1:8) for different GABA concentrations (Figure 4-18).It is known that GABA 
and GLU maintains a certain balance in the human brain through the glutamate-
glutamine(GABA) cycle[110] And they exist in a certain molarity ratio based upon the 
state of the brain. For example, in epilepsy, this cycle becomes imbalanced and GLU 




Figure 4-17: GABA probe calibration in different concentrations of Glutamate, GLU 
(5, 10, 20, 40, 80 μM). A, B. shows current response and linear fitting at GABA 
microbiosensor in Site 2 with and without GABA. Arrows indicate GLU infusion 
Legends: no GABA (red solid curve), 5 μM GABA (blue), 10 μM GABA (green) and 
20 μM GABA (magenta). Linear fit parameters obtained for GLU with different 
concentration of GABA : no/0μM GABA (red line), GLU sensitivity = (132 ±9  
nAμM-1cm-2), R2 =0.99973; 5μM GABA (blue line) GLU sensitivity = (146±7 nAμM-
1cm-2), R2 =0.99921; 10μMGABA (green line),GLU sensitivity = (156±12 nAμM-
1cm-2); R2 =0.99927 and  and20μM GABA  (magenta line), GLU sensitivity = 
(168±19 nAμM-1cm-2); R2 =0.99863 at GABA microbiosensor. The microbiosensor 
was biased at + 0.7 V vs Ag/AgCl reference. The solution was stirred at 200 rpm and 
maintained at 37 ° C. No α-ketoglutarate added during all the experiments [14]. 
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The data clearly suggest that the IGABA increases as GABA and GLU levels 
increases. This is evident from Figure 4-18, which shows that, for a given GABA 
concentration, the IGABA value is larger for higher GABA: GLU ratios. So, in this 
approach, for a given IGABA value, the GABA concentration can vary. To get the GABA 
concentrations we also need the GLU concentration of the outer environment. To get the 
GLU and GABA concentration we propose our novel method in the next section. 
 
Figure 4-18: A&B: shows the IGABA values for different GABA (5, 10 and 20 μM) and 
Glu concentrations (5, 10, 20, 40, 80 μM). Legends: 5 µM GABA (red bar/line), 10 
µM (green bar/line) and 20 µM (blue bar/line). B.10, 20, 40 and 80 µM Glutamate. 
C.The IGABA values at different GABA: GLU molarity ratios. Legends: GABA:GLU= 
1:1 (red), 1:2 (green), 1:4 (blue) and 1:8 (cyan bar) [14]. 
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4.9 Quantification of GABA and GLU 
Since our GABA sensor is based on GLU concentration, only IGABA value cannot 
give GABA concentration. We need determine the local GLU concentration first to get 
our GABA concentration. The steps are explained with examples below. Figure 4-19 
shows the total calculation steps. 
1. GLU concentration [GLU] is derived from 1-18-(B), e.g. for 4200 nAcm-2, 
[GLUE]= 45 µM  
2. This is also the x-coordinate of 1-18-(C); e.g. [GLUE]= 45µM  
3. We get IGABA from (D). IGABA is the difference in current recorded from 
the GABA and GLU microbiosensor in the presence of known GABA 
concentration.  At 20 µM GABA, current is 7400 nAcm-2 and for 0 µM 
GABA the current is 4200 nAcm-2 (GLU only). Thus, IGABA is 3200 nAcm-2. 
We Use this value for step 4. 
4. The intersection of x-y coordinates in (C) gives [GABA]. In this case 45 
µM (x) and 3200 nAcm-2 (y) intersect at the 20 µM GABA line. (4) 
5. Therefore, GLU concentration in this case is 45µM and GABA 
concentration is 20 µM. 
Ideally, we do the calibration values (for GABA and GLU) before the ex-vivo and 
in-vivo experiments. However, with time our electrodes foul and the sensitivity values 
deviate from pre-experiments calibrations. We can solve this problem by installing a 
microfluidic flow channel in our probe which can help us do in-situ calibration. 
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Figure 4-19: Scheme for calculating GLU and GABA calculation. A. Shows the 
sensor positions. B, C and D. show different steps to determine the eventual GLU and 











WIRE BASED SENSOR FOR NEUROCHEMICAL DETECTION 
 
5.1 Sensor Fabrication 
In the first step, Teflon® coated, 127-µm diameter Pt wire (#77300, AM-systems, 
Sequim, WA) was cut into 4-cm lengths with a PXC058 tube cutter (Coilhouse 
Pneumatics, East Brunswick, NJ). One cut end served as the recording side. On the other, 
non-recording side, a 1-cm length of Teflon® coating was gently stripped away using a 
steel scalpel blade. This end was wrapped around a gold coated nickel electrical 
connector pin (#3128-4-00-15-00-00-08-0, Mouser Electronics, Mansfield, TX). The 
contact region between the wire and the connector pin was then covered with a 3/64” heat 
shrink wrap (HS-TBG 3/64” 2:1 CL, Mouser Electronics, Mansfield, TX) to provide an 
adequate, seamless electrical contact between the biosensor and the pin that was 
eventually in contact with the connector (ED 3013-ND, Digi-key, Thief River falls, MN) 
that is in contact with the potentiostat  (FAST-16MkIII  ,Quanteon, LLC, 
Nicholasville,KY).The exposed Pt microwires were electrochemically cleaned using 
cyclic voltammetry (CV) method. The CV was run in a 2-electrode setup using Ag/AgCl 
reference in a 0.05 M H2SO4 electrolyte solution and the potential was cycle between 
−0.3 V to +1.0 V at a 20 mV/s scan rate for 15 cycles.  After the microwire cleaning, they 
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were heated in an oven at 65° C for 20 min. The Pt microwires were then calibrated to 
measure their sensitivity towards H2O2, the electroactive by-product of the 
microbiosensor shown in Figure 5-1. This initial calibration helps to make sure the three 
different channels (GABA, GLU and sentinel) have same sensitivity towards 
H2O2.Different H2O2 sensitivity will suggest different electroactive area. This is not 
acceptable since we need uniform area in all three wires.  The microwires were stored dry 
at room temperature in a clean plastic container until ready for the enzyme coating. 
 
Figure 5-1: H2O2 calibration and sensitivity in different sites. A. Calibration of 
different sites with 1, 2 and 3 µM H2O2, GABA site (black), GLU site (red) and 
sentinel site (blue). Amperometry: + 0.7 V vs Ag/AgCl wire in a stirred 1X PBS 
beaker; the stir rate was 200 rpm. B. shows the H2O2 sensitivity in different sites 
(Green bars). Error is shown as mean± SEM. 
After the completion of the H2O2 calibration, enzyme solutions were drop-casted 
onto the recording end of the Pt microwires (details in Hossain et.al., [14]). Briefly, a 
fresh enzyme matrix solution was prepared that contains BSA (1%) and glutaraldehyde 
(0.125%) in DI water. This solution was mixed with 0.1 U/mL GOx for the GLU 
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microbiosensor and a mixture of 0.1 U/mL GOx and0.1 U/mL GABASE for the GABA 
microbiosensor. The third microwire, called a sentinel microsensor, was constructed by 
applying only the enzyme matrix solution (i.e., it does not contain any GOx or GABASE 
enzymes). The sentinel microsensor plays an important role in measuring the amounts 
(and concentrations) of all the electroactive molecules present in the vicinity of the 
biosensor probe such as ascorbic acid (AA) and that can be easily oxidized at the +0.7 V 
applied to all three microsensors. The enzyme coated microwires were stored in the dark 
at room temperature for 48 hours.  
Once the enzyme is cross-linked with the enzyme matrix, a size-exclusion layer of 
m-phenylenediamine (mPD) was electrochemically coated onto all three coated 
microwires. 10 mM mPD was prepared in 1 M NaCl and then purged with nitrogen for 
30 min before use. Cyclic voltammetry scans between +0.2 V and +0.8 V, scan rate 50 
mV/s for 100 cycles (40 minutes), using a saturated calomel electrode as a reference 
electrode, were performed to form a size-exclusive mPD layer. This provides selectivity 
or specificity to the microbiosensor by preventing the diffusion of the interferents, 
primarily AA, that are present in high concentrations (up to millimolar range [97]). After 
the coating, the freshly prepared microbiosensors are stored in a dry, dark cool place until 
they are assembled into a probe. 
Finally, the ends of the three coated microwires were bound together with a 
bigger heat shrink wrap shown in Figure 5-2 and inset (#103-0246, Nordson Medical, 
Salem, NH).The shrink wrap provided protection of the thin Teflon® wire coating 
against abrasion, and it placed the wires very close to each other (Figure 5-2) and held the 
ends of the wires in the same recording plane. It also added rigidity to the microwire 
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probe for improved handling during experiments.  Electrical continuity for each biosensor 
channel was confirmed using a FAST-16MkIII potentiostat (Quanteon, LLC, 
Nicholasville, KY).  
For in-vivo recording, A barbed leur lock cap (51525K125 nylon quick-turn 
barbed plug 3/16” inside diameter, McMaster-Carr, Elmhurst, IL) was used to secure the 
biosensor to a permanently implanted guide cannula with a male luer lock fitting. The 
microwires were inserted through the opening in the cap so that the end of the microwire 
bundle would protrude 100-µm beyond the end of a permanently implanted guide cannula 
for in vivo recording. For our system, this length was 4.0 cm. A Teflon-insulated 
Ag/AgCl wire was also inserted through the cap to connect to the reference electrode 
integrated into the cannula. 6 cm of insulation was stripped from the end of the wire and 
then the wire was twisted into a loop around the luer lock cap so that the stripped portion 
will make a secure electrical contact with a similar loop of Ag/AgCl wire integrated into 
the connector of the cannula. The remainder of the Ag/AgCl wire was threaded through 
the cap and cut 0.3 cm above the top end of the cap. This end of the wire was stripped 
and soldered to a male pin connector (520200, A-M Systems, Sequim, WA). We secured 
the wires into the cap using dental acrylic (Ortho-Jet BCA, Lang Dental Manufacturing 
Company, Inc., Wheeling, IL). Electrical continuity for each biosensor channel was 
confirmed using a FAST-16MkIII potentiostat (Quanteon, LLC, Nicholasville, KY). The 
packaging is shown in Figure 5-2. 
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Figure 5-2: Sensor packaging. A. Shows the sensor after heat shrink wrapping and 
connecting to digi-key connector that eventually connects to the potentiostat. B. 
Shows optical microscopy image of the three sensor sites. The probe consists of three 
surfaces modified platinum microwires that are packaged using heat shrink tubing. 
Those three microwires eventually become GABA, GLU and sentinel sites. C. Sensor 
packaging for in-vivo application. 
5.2 Wire Characterization 
After the sensor is packaged, we do our first electrochemical characterization for 
the wires (sites) shown in Figure 5-3. This characterization is to make sure all our 
enzymes are active and the size-exclusion layer blocks interferent molecules, in our case 
Ascorbic acid (AA) is the main intereferent. For our calibration we calibrated the wires 
using 20-80 μM GABA and 5-20 μM GLU. We also use 100 μM AA to examine the 
effectiveness of our mPD layer.  
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Figure 5-3: Characterization of the different channels (sites) in our packaged sensor. 
A. Shows the GABA and GLU signal in all the channels. GABA channel (black line), 
GLU channel (red line) and sentinel channel (blue line). GABA channel is coated 
with 0.1 unit/μL GABASE+0.1 unit/μLGOx and GLU channel is coated with 0.1 
unit/μLGOx. Sentinel channel has no enzymes.  The experiment is done in 1mM α-
ketoglutarate with a stirring rate is 200 rpm at 37°C temperature. Amperometry 
parameters: +0.7V vs Ag/AgCl. B. Shows the signal against GABA concentration in 
GABA channel (black dots). Slope: 16.92±1.12 nA/μMcm2 ; R2=0.9807 C. shows the 
signal against GLU  concentration in GABA channel (black dots) Slope: 94.64±9.12 
nA/μMcm2 ;R2=0.996and GLU channel (red dots). Slope: 83.64±6.4 nA/μMcm2 ; 
R2=0.998. Error values are shown as mean± SEM. The microwire probes are stored at 
4°C. 
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As we expect, the GABA channel is sensitive towards GABA and GLU but the 
GLU channel is sensitive towards GLU only. This is due to the fact that, GLU channel 
does not have GABASE enzyme. In contrast, the sentinel wire is not responsive to any of 
the neurochemicals for lack of enzymes. Therefore, it has neither sensitivity nor 
selectivity against GABA or GLU. Additionally, all the channels show low sensitivity 
towards AA demonstrating effectiveness of our mPD layer. Table 5-1 shows the 
sensitivity, selectivity and limit of detection (LOD) in different wires.  
Table 5-1: Shows the sensitivity (nA/µM.cm-2) of GABA (SSGABA) and GLU(SSGLU), 
selectivity(no unit) of GABA (SEGABA) and GLU(SEGLU), and LOD (µM) values of 
GABA (LODGABA) and GLU (LODGLU) for different channels.  
Channel SSGABA SEGABA SSGLU SEGLU LODGABA LODGLU 
GABA 17±2 29±7 95±10 123±27 2 ±0.66 0.20 ±0.01 
GLU - - 84±7 106±21 - 0.25 ±0.01 










5.3 GABA Working Range Determination 
As we have done with our 8-TRK probes, with the wires we need to determine the 
linear range for GABA and see if the response follows Michealis-Menten theory. To do 
this experiment we coat the GABA channel with GABASE and GOx, GLU channel with 
GOx and sentinel with no enzymes just like before. After that we calibrate all of these 
channels in our beaker. For GABA we do the calibration in 50-2200 μM range. These 
concentrations are relevant for tissue stimulation study, discussed in subsequent chapters.  
Figure 5-4 shows the response against GABA in all the channels. As we expect, 
we only observe GABA response in the GABA channel because of presence of 
GABASE. The GLU and sentinel channel does not give this response. The GABA 
response all follows Michealis-Menten theory. The GABA response is linear from        
0-500μM GABA but after that range the response is not linear anymore as shown in 
Figure 5-4 (inset). It shows if GABA concentration is less than or equal to 1800 μM the 
GABA channel responds. However, Figure 5-4 also shows when GABA concentration is 
>1800 μM the sensor saturates (no increase in signal with increasing GABA 
concentration). From these experiments, we can say 50-1800 μM is the working range for 
GABA channels. However, the GABA linear range is 0-500 μM and in the linear range 
the sensitivity is 1±0.16nA/µMcm2.   
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Figure 5-4: GABA response in all the channels. A. Shows response at 50-2200 μM 
GABA. The arrows show the infusion point and the numbers represent GABA 
concentration in μM. GABA channel (black line), GLU channel (red line) and sentinel 
channel (blue line). GABA channel is coated with 0.1 unit/μL GABASE+0.1 
unit/μLGOx and GLU channel is coated with 0.1 unit/μLGOx. Sentinel channel has 
no enzymes.  The experiment is done in 1mM α-ketoglutarate with a stirring rate is 
200 rpm at 37°C temperature. Amperometry parameters: +0.7V vs Ag/AgCl. B. 
Shows response against GABA concentration. C. Shows response against GABA 
concentration in the linear range. Linear fitting parameter: slope 0.96±0.15 
nA/µMcm2; R2= 0.982. Error values are shown as mean± SEM. The microwire probes 
are stored at room temperature. 
 
90 
5.4 Glutamate Working Range Determination 
To keep consistency with our earlier works, with the wires we need to determine 
the linear range for GLU and see if the response follows Michealis-Menten theory. To do 
this experiment we coat the GABA channel with GABASE and GOx, GLU channel with 
GOx and sentinel with no enzymes just like before. After that we calibrate all of these 
channels in our beaker. For GLU we do the calibration in 20-1200 μM range. These 
concentrations are relevant for tissue stimulation study, discussed in subsequent chapters.  
Figure 5-5 shows the response against GLU in all the channels. As we expect, we 
observe GLU response in both GABA and GLU channel because of presence of GOx. 
The sentinel channel does not give this response. The GLU response all follows 
Michealis-Menten theory. The GLU response is linear from 0-300μM GLU in both 
GABA and GLU channel but after that range the response is not linear anymore as shown 
in Figure 5-5 (inset). It shows if GLU concentration is less than or equal to 1000 μM both 
the GABA channel and GLU channel responds to GLU. However, Figure 5-5 also shows 
when GABA concentration is greater than 1000 μM the sensor saturates (no increase in 
signal with increasing GABA concentration). From these experiments, we can say 0-1000 
μM GLU is the working range for both GABA and GLU channels. However, the GLU 
linear range is 0-300μM and in the linear range the sensitivity is 144±20 nA/µMcm2 for 
GABA channel and 112±17 nA/µMcm2 for GLU channel. These microwire probes are 
stored at room temperature. 
91 
 
Figure 5-5: A. Shows response at 20-1200 μM GLU. The arrows show the infusion 
point and the numbers represent GLU concentration in μM. GABA channel (black 
line), GLU channel (red line) and sentinel channel (blue line). B. Shows response 
against GLU concentration in GABA channel and GLU channel C. Shows response 




5.5 GABA Calibration in presence of Glutamate 
In these experiments we did the GABA calibration in presence of GLU as we 
have in Chapter-4. For these experiments we calibrate GLU in 10-300 µM range in 
various GABA concentrations. We did the GLU calibration in 1X PBS+ no GABA, 1X 
PBS+ 50 µM GABA, 1X PBS+ 100 µM GABA, 1X PBS+ 300 µM GABA, 1X PBS+ 
500 µM GABA and 1X PBS+ 1000 µM GABA.  The responses are shown in Figure 5-6. 
 
Figure 5-6: Glutamate responses in the GABA channel for different GABA 
concentration. The GLU response in the sentinel line is shown as black line.  
As we can see from the Figure 5-6 ,with increasing GABA concentration the GLU 
signal increases too. When GABA is present in the solution, the H2O2 current response is 
from both GABA and GLU oxidation and we expect it to be larger than the response 
when there was no GABA. Therefore, higher GABA concentrations appear to induce a 
greater response GABA channel and greater IGABA, which is the GABA signal. Therefore, 
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the GLU sensitivity in GABA channel increases with higher GABA concentration, 
whereas the GLU sensitivity in the GLU channel remains almost similar (no considerable 
increase/decrease in the signals). The apparent equal sensitivity can also be taken as proof 
that the increase in sensitivity in GABA channel is due to GABA concentration s and not 
random. Table 5-2  shows the sensitivity of the GABA and GLU channels for different 
GABA concentrations.  
Table 5-2: Sensitivity (SS, nA/µMcm2) different GABA concentrations. Sensitivity at 
0µM GABA is shown as SS0, Sensitivity at 50µM GABA is shown as SS50, and so 
forth.   
Channel SS0 SS50 SS100 SS300 SS500 SS1000  
GABA 104±12 120±18 128±17 152±21 184±27 224±41 
GLU 55±7 64±10 45±8 44±6 43±7 41±9 
 
The LOD in GABA and GLU channels for different GABA concentration. LOD 
is in the hundreds of nanomolar (nM) range as shown in Table 5-3. It is consistent with 
results we got in the Chapter-4.  We can get IGABA same way we discussed in Chapter-4. 
More about IGABA and how it can be used to get GLU and GABA concentration is 
discussed in the next section. Table 5-3 shows the LOD of both these channels. The 





Table 5-3: Limit of detection (LOD, µM) for different GABA concentrations. LOD at 
0µM GABA is shown as LOD0, Sensitivity at 50µM GABA is shown as LOD50, and so 
forth.   
Channel LOD0 LOD50 LOD100 LOD300 LOD500 LOD1000  
GABA 0.15±0.01 0.13±0.02 0.12±0.01 0.10±0.02 0.08±0.01 0.07±0.001 
GLU 0.26±0.03 0.23±0.05 0.33±0.02 0.34±0.09 0.36±0.11 0.38±0.127 
 
5.6 Quantification of GABA and Glutamate 
Determining the GABA and GLU concentration follows similar process we 
discussed in Chapter-4. We observed the current difference between the GABA and GLU 
site. We observed increased current densities with increasing GABA concentration. 
Figure 5-7 shows this trend. If we subtract the current at a certain GABA concentration 





Figure 5-7: Current difference between GABA and GLU channel.  Legends: no 
GABA (black dots), 50 µM GABA (red dots), 100 µM GABA (green dots), 300µM 
GABA (blue dots), 500 µM GABA (cyan dots) and 1000 µM GABA (magenta dots). 
Linear fitting parameters: no GABA: slope= 40±5 nA/µMcm2; R2=0.999, 50 µM 
GABA: slope= 51±11 nA/µMcm2; R2=0.995, 100 µM GABA: slope= 83±13 
nA/µMcm2; R2=0.988, 300 µM GABA: slope= 102±13 nA/µMcm2; R2=0.993, 500 
µM GABA: slope= 138±17 nA/µMcm2; R2=0.992 and 1000 µM GABA: slope= 
197±26 nA/µMcm2; R2=0.992. Error values are shown in mean ± SEM. 
We plot GLU response against GLU concentration as shown in Figure 5-8. It is 
the environmental GLU (GLUE) as we’ve seen in earlier chapter. With the values of  
IGABA, we plot IGABA against the GLU concentration for different GABA concentrations as 
shown in Figure 5-8. Firstly, we determined the   peak current in sentinel wire (e.g. 30 
pA). After that, the peak current in GLU wire was calculated (e.g. 470 pA). The 
difference of these currents is the GLU current (e.g. 470-30=440 pA). Then, from the 
calibration curve GLU conc. was calculated. (e.g. if sensitivity of GLU wire is 10 pA/μM 
then GLU concentration in this case is 440/10=44 μM), shown in Figure 5-8. 
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 Next, we determined the peak current in GABA wire (e.g. 2000 pA). Then 
according to the GLU sensitivity of the GABA wire, we subtracted the current from 
GABA wire current. (e.g., If the GLU sensitivity of the GABA wire is 15 pA/μM; then 
we subtract 15*44= 660 from the 2000 pA. 2000-600=1400 pA). The difference between 
the sentinel and the current above is our IGABA (e.g. 1400-30= 1330 pA). Finally, from the 
GLU conc. and IGABA we get the GABA conc. with the help of calibration curve shown in 
Figure 5-8. 
 
Figure 5-8: Scheme for quantification procedure for GABA and GLU concentration. 
A. GLU calibration in 1X PBS for GLU wire, we will get out GLU concentration 
from here. Linear parameters for the line: Slope=61 ± 6.4 nA/µMcm2; R2= 0.934 B. 
shows the difference in current, IGABA vs GLU concentration, we will get our GABA 
concentration from here. Linear parameters: for 50μM GABA line, slope= 12 ± 3.8 
nA/µMcm2; R2= 0.939; for 100μM GABA line, slope= 36 ± 12; R2= 0.966; 300μM 
GABA line, slope= 64 ± 16 R2= 0.967; 500μM GABA line, slope= 100± 21; R2= 
0.978 and for 1000μM GABA line, slope= 161± 25; R2= 0.986. Error values are 






REAL-TIME GABA AND GLUTAMATE MEASUREMENT 
 
6.1 GABA and Glutamate Measurement in 8-TRK Probe 
6.1.1 Probe modification for GABA and GLU Measurement in Rat Brain Slices 
Hippocampal slices were prepared from an adult Sprague Dawley rat. The tissue 
slice is 400μm thick. However, as discussed in chapter-4 the sites (electrodes) in 8-TRK 
are 2mm apart. To solve this problem, we brought the sites closer. Figure 6-1 shows the 
new configuration of the GABA and GLU sites. The distance between the electrodes is 
now 100 μm, which is comparable to tissue thickness (400 μm). 
Enzyme coating was done in the GABA and GLU sites in the same process as 
discussed in Chapter-4. Additionally, to block interferent molecules we also coated a 
mPD layer. The mPD layer was electrochemically deposited using Cyclic voltammetry 
between +0.2 V and +0.8 V, 50 mV/s, 20 min in 10 mM mPD solution. A calibration 
curve was constructed before performing the ex vivo recordings in order to convert 
current from GABA release to GABA concentration at the probe. This calibration curve 
is constructed based on the procedure detailed in Figure 4-16. The data plotted in Figure 
6-1  is constructed in the same way as that of Figure 4-19. This IGLU and IGABA can be 
used to get GABA and GLU concentration. 
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Figure 6-1: A. Shows the new probe placements. The distance between the sites is 100 
μm. B. Current signals for varying Glu concentrations (5, 10, 20, 40, and 80 μM, blue 
dots) and the linear fit (black dashed). Linear fit parameters: Glu sensitivity: 58.2 ± 3 
nA/μMcm2, R2= 0.99364. C. IGABA for varying Glu concentrations. Legend: 5 μM 
GABA (red dots), 10 μM GABA (green dots) and 20 μM GABA (blue dots); linear fit 
for 5 μM GABA (red dashed), linear fit parameters: slope = 4.2 ± 0.12 nA/μMcm2, 
R2= 0.99699, the linear fit for 10 μM GABA (green dashed), linear fit parameters: 
slope = 12.6 ± 1.8  nA/μMcm2, R2= 0.9699 and linear fit for 20 μM GABA (blue 







6.1.2 Real-time measurement of GABA and Glutamate in Rat Slice 
Simultaneous and continuous real-time detection of GABA and glutamate (GLU) 
was accomplished using electrically stimulated release in a hippocampal slice model. We 
used a range of 100 μA pulse widths to induce release of the neurotransmitters as shown 
in Table 6-1 to determine the responsiveness of the sensor to varying levels of stimulation 
which included single pulses ranging from 1s to 25 ms in duration and a pulse train of ten 
5 ms pulses. Figure 6-2 shows the signals in both the electrodes in different pulses. 
 
Figure 6-2: Ex-vivo recording of stimulated release of Glu and GABA in rat 
hippocampal slice preparation. A. Current responses to unipolar stimulation (tungsten 
wires, 100 μA) are shown. Stimulation pulse parameters (Pulse A–E) and conversion 
of peak current measurements to Glu and GABA concentrations are discussed for 
points 1 and 2 in subsequent sections Insets B, C, and D show details of the responses 
to shorter pulse widths [14]. 
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The GABA signal was derived by subtracting the signal from the GOx-coated 
glutamate microbiosensor from the GABASE-GOx-coated GABA microbiosensor. The 
GABA signal and GLU signal is represented in Figure 6-3.  As expected, the amplitude 
of GABA and glutamate release scaled with pulse width (Figure 6-3). In some cases, 
GABA had shorter peak duration, and in all cases the concentration of GABA rose faster 
than glutamate concentration (Figure 6-3).  
 
Figure 6-3: Ex vivo recording of stimulated release of Glu and GABA in rat 
hippocampal slice preparation. A. Processed GABA signal with Glu signal from 
responses to all stimulations in Figure 6-2. The GABA trace (blue trace) is the 
difference between the signals from the GABA-glutamate and the Glu microbiosensor 
sites (red trace). B. Inset shows the rise time, tr10-90, for the GABA signal (blue curve) 
and the Glu signal (red curve) from the boxed region in A. Arrows indicate the slope 
of line drawn from tr10-90 for GABA (blue arrow points to line) and tr10-90 for Glu (red 
arrow points to line). The rise times for GABA were faster than for Glu, as the 
difference in the slopes of the lines illustrate[14]. 
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For example, the mean rise time (±SEM) for a 25-ms stimulation was 6.94±0.9 s 
for GABA and 3.12±0.35 s for glutamate (n = 6, p<0.05). The rise time along with the 
pulse characteristics is shown in Table 6-1.The general trend we see here is with 
increasing time of the stimulation gives us higher rise time for both GABA and GLU 
signals. This is due to higher number of neurons firing in high duration pulses. 












A 1000 ms single pulse 25±2.2 17±1.24 8±1.2 
B 250 ms single pulse 19±1.9 14±1.1 5±0.45 
C 50 ms single pulse 7±0.85 12±1 5±0.6 
D Ten 5-ms pulses 
separated by 1 ms 
7±0.8 12±1 5±0.75 
E 25 ms single pulse 4±0.25 7±0.9 3±0.35 
 
Both GABA and glutamate leak out of neuronal synapses after neurons release 
these neurotransmitters. Mechanisms exist to quickly scavenge and recycle these 
neurotransmitters, but some molecules diffuse through the extracellular space [25], [111], 
[112]. Thus, the there is a slight delay from stimulation to response, as well as a long 
decay period as GABA and glutamate are eventually cleared. Both of these dynamic 
processes are evident in the traces shown in Figure 6-3with a rapid, but not immediate 
increase in neurotransmitter concentration, and a slower decline to baseline representing 
release and uptake, respectively. 
102 
Peak current measurements in is shown in Table 6-2 represent a range of stimulated 
release of GABA and glutamate. These measurements correspond to curves labeled 1and 
2 in Figure 6-2. Peak concentrations ranged from 5 – 35 µM for glutamate and 5 – 13 µM 
for GABA. The steps of calculating each parameter is shown below the table. 










1 74 35 25 13 
2 10 5 6 5 
 
1Number corresponds to signal trace number in Figure 6-2. 2From Figure 6-2, the 
IH2O2(E) value, i.e. the local Glu signal is measured. 3Then the local GLU concentration is 
known from Figure 6-1. 4The difference in signal, i.e. IGABA value is the difference 
between the IH2O2values obtained from the two microbiosensors in Figure 6-3. 5Now, 
knowing the GLU concentration, which is the x-coordinate in Figure 6-1(C) and the 
IGABA value, which is the y-coordinate in Figure 6-1(C), one can find the GABA 
concentration for the two points. Thus, these microprobes can measure GABA and 
glutamate at concentrations that are well below normal levels [28],[103] making them 
suitable to study impaired release in disease states. Furthermore, numerous cycles of 
stimulated release with consistent current amplitude for each level of stimulation and 
without adding any exogenous substrates, such as α-ketoglutarate, support the premise 
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that endogenous products of the conversion of glutamate provide the substrate for the 
GABASE reaction. This is an important capability for future in-vivo applications. 
6.2 GABA and Glutamate Measurement in Microwire Probe 
6.2.1 GLU and GABA Release is Dependent on Stimulation Frequency 
We used three stimulation frequencies, 10, 50, and 140 Hz, to evoke GLU and 
GABA release.  Each of these stimuli issued 5s trains of 100 µA square pulses with 1ms 
width. We randomized the types of stimulations to avoid systematic error. Prior to 
initiating the next stimulation, we allowed current responses to return to baseline to avoid 
effects from potentiation. Between subsequent stimulation, we used a single 100ms 
control pulse (100 µA square pulse). Control pulses produced the same GLU response 
throughout each recording session indicating that brain slices were in good health and 
that stimulation-induced  potentiation  has not occurred [96].  
Both GABA and GLU current increased with increasing stimulation frequency. 
Representative traces of responses to randomized stimulation are shown in Figure 6-4. 
The common pattern we observed here is the lower stimulation pulse (10 Hz) gave 
smaller signals for both GLU and GABA. With increasing frequency, the signals rose 
higher. We made sure that the control pulse response similar throughout the recording. 
When we saw a change in our control pulse, we concluded our tissue is no longer healthy 
for recording. At this point, we start recording from a different tissue. Figure 6-4 also 
shows response for different stimulation frequencies. The responses were significantly 
different in terms of amplitude and rise time/fall time. It is evident with the use of 




Figure 6-4: Microwire biosensor current in response to three different stimulation 
frequencies. A. Representative recording of current in response to 100 μA stimulation 
with 10, 50, or 140 Hz pulse trains, denoted by A, B, C (red font), respectively and to 
a single 100 ms control pulse indicated by green downward arrows. B-E. Details of 
selected current responses to 10, 50 and 140 Hz stimulation from Panel A are shown 
in C, D, and E, respectively. The control pulse is shown in B. In all these cases the 
black traces indicate the signal in GABA channel, red traces indicate signal in GLU 
channel and blue traces indicate the signals in sentinel channels. GABA channel is 
coated with 0.1 unit/μL GABASE+0.1 unit/μLGOx and GLU channel is coated with 






6.2.2 Extracellular Concentration of GLU and GABA 
Peak concentration increased as stimulation frequency increased for both GABA 
and GLU as shown in Figure 6-5. GABA concentration increased in a linear fashion 
whereas GLU increase was not linear Figure 6-5. GLU concentration increased to a lesser 
extent between 50 and 140 Hz than between 10 and 50 Hz, perhaps due to inhibition from 
increased GABA. Furthermore, both GLU and GABA concentrations were higher after a 
single stimulation (100-ms control pulse) than after 10 Hz stimulation. GLU 
concentration increased significantly from 50± 5 µM to166 ± 28 µM when the 
stimulation frequency was increased from 10 to 50 Hz. GLU concentration rose to 264 ± 
43 µM (mean ± SEM) when the stimulation frequency was increased to 140 Hz, although 
the increase in concentration from 50 to 140 Hz pulses represented a non-significant 
trend (p = 0.063). However, the difference in concentration between 10 and140 Hz 
stimulation was significant. 
Similarly, GABA concentration increased from 72±14 µM to 296± 53 µM from 
10 Hz to 50 Hz stimulation, and it rose further, to 793 ± 27 µM (mean ± SEM) in 
response to 140Hz pulses. In addition, mean peak GLU and GABA concentrations were 
significantly different in response to the control pulse. Furthermore, the difference was 




Figure 6-5: Peak GLU and GABA concentration. A. Mean peak GLU concentration 
for different stimulation. B. Mean peak GABA concentration for different stimulation 
C. Lines on the scatter plot show that the rate of increase in extracellular GLU (blue) 
and GABA (red).  Results are shown as mean ± SEM (error bars). Statistically 
significant differences are denoted by asterisks over horizontal brackets in A and B; in 
C (independent Wilcoxon tests, * p ≤ 0.05, ** p < 0.01, *** p < 0.001). (Data 




6.2.3 Response Characteristics of GLU and GABA peaks 
Dynamic features of extracellular GLU and GABA release, evident in the shape 
of the current peaks, scaled with stimulation frequency. For example, both the rise time 
(TR) and the decay time (TD) of GLU and GABA peaks increased as stimulation 
frequency increased (Figure 6-6 and Figure 6-7). In general, the duration of the peaks 
(FDHM, Figure 6-6 and Figure 6-7) scaled with increasing stimulation frequency except 
for a non-significant difference between GLU peak duration after 50 and 140Hz pulses.  
Interestingly, for the single control pulses, mean GLU and GABATR values were 
similar to 50Hz stimulation, whereas mean GLU and GABA TD and FDHM values were 
most similar to 10 Hz stimulation. No differences were observed between GLU and 
GABA for the same parameter and stimulation frequency. Increased stimulation 
frequency produced higher concentrations of GLU and GABA. This could be due to 
recruitment of a greater number of glutamatergic neurons and GABAergic neurons, 
and/or longer firing periods of the same population of cells, in response to higher 
frequency stimulation. In either scenario, more neurotransmitters are released which 
would take longer to diffuse toward the biosensors, and require more time for astrocytic 
uptake.  Thus, it is not surprising that TR, TD and FDHM increased as the concentration 
of GLU and GABA increased. The decay time for GLU is shown in Figure 6-6 and for 
GABA it is shown in Figure 6-7. For the GLU signal there was no significant difference 
between decay time in 50 Hz and 140 Hz stimulation. The same pattern is not observed in 
the GABA response, for 50 Hz and 140 Hz there is no significant difference in GABA 
response decay time (see APPENDIX C for all wilcoxon p-values). 
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Figure 6-6: GLU peak characteristics. Rise time (A, TR), decay time (B, TD), and 
duration (C, FDHM) of extracellular GLU release increased as stimulation frequency 
increased. A. Differences in mean rise times between 10, 50 and 140 Hz for GLU. B. 
Differences in mean decay times between 10, 50 and 140 Hz for GLU C. Differences 
in mean FDHM times between 10, 50 and 140-Hz for GLU * p < 0.05, ** p < 0.01, 




TD and FDHM, in combination, show the decay time for the signal. Taking these 
results together we can conclude that the decay time is higher than the rise time. It also 
makes sense because the GLU signal increase is thought be originated in the neuronal 
firing which is in millisecond range. In contrast the decay is probably due to the uptake of 
GLU in astrocytes which takes few seconds. 
6.2.4 E:I ratio of Excitatory Glutamate and Inhibitory GABA 
GLU is the major excitatory (E) neurotransmitter in the brain and GABA is the 
major inhibitory (I) neurotransmitter. Both are plentiful in CA1. We calculated the ratio 
of GLU to GABA concentration (E: I ratio) for each stimulation condition (Figure 6-8). 
Mean E:I ratios for a single control pulse and 10, 50 and 140Hz pulses, were0.64 ± 0.10, 
1.27 ± 0.26, 0.54 ± 0.09 and 0.36 ± 0.06 (mean ± SEM), respectively. This trend toward 
lower E:I ratios as stimulation frequency increased was significant between 10Hz and 
50Hz, and 10Hz and 140Hz pulses, and between control and 10Hz stimulations. The 
reduction in the E/I ratio from 50Hz to 140Hz stimulation was a non-significant trend (p 
= 0.09), see APPENDIX C for all wilcoxon p-values. Durand et al. showed seizure 
suppression by high frequency optogenetic stimulation in hippocampus of animal models 
of epilepsy, where the suppression was attributed to the activation of GABA receptors in 
GABAergic interneurons [113]. This work and others have demonstrated that electrical 
high frequency stimulation suppress seizures by generating a depolarization block related 
to the inactivation of sodium channels or driving GABA release during stimulation. 
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Figure 6-7: GABA peak characteristics. Rise time (A, TR), decay time (B, TD), and 
duration (C, FDHM) of extracellular GABA release increased as stimulation 
frequency increased. A. Differences in mean rise times between 10, 50 and 140 Hz for 
GABA. B. Differences in mean decay times between 10, 50 and 140 Hz for GABA C. 
Differences in mean FDHM times between 10, 50 and 140-Hz for GABA * p < 0.05, 
** p < 0.01, *** p < 0.001. (Data provided by T.A. Murray) 
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Figure 6-8: The ratio of peak concentrations of GLU (excitatory input, E) and GABA 
(inhibitory input, I). Significant decreases occurred between 10 and 50 Hz and 10 and 
140 Hz stimulation. A non-significant trend toward lower E: I value was observed for 
higher frequency stimulation between 50 and 140 Hz (p = 0.09). Wilcoxon ranked 
sum test, * p < 0.05, ** p < 0.01. (Data provided by T.A. Murray) 
In addition, it has been estimated that a single GABAergic cell may affect more 
than a thousand pyramidal cells [114]. Therefore, activation of GABAergic neurons 
becomes dominant at high frequency stimulation, which led to a recovery of the E/I 
balance and seizure suppression. In our work, we observed a huge activation of 
GABAergic neurons at 140 Hz. This excess GABA could have reduced excitatory 
synaptic transmission by decreasing excitatory postsynaptic potentials and GLU release 
and even block action potential propagation as suggested in literature [115],[116]. 
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6.2.5 In vivo Recordings in Freely Moving Rat 
We recorded GABA and GLU in an awake, freely moving rat two weeks (Wk 2) 
after guide cannula implantation and again during week 10 and week 16 which was eight 
and fourteen weeks, respectively, following the first recording (Figure 6-9). Freshly 
calibrated microwire biosensors were inserted into the permanently implanted cannula for 
each recording session. In between recordings, a filler wire was inserted into the cannula 
to maintain the patency of its lumen. After acquiring baseline recordings, we employed 
the lithium-pilocarpine model of epilepsy to induce epileptogenesis. Current traces shown 
in Figure 6-9. are after subtraction of sentinel current for both biosensor channels and 
also after subtraction of GLU current from the GABA channel. For better visualization, 
we did not include the sentinel channel; we also down sampled and used a moving 
average to better visualize GLU and GABA baselines. GLU and GABA dynamics were 
markedly different between various behaviors, which included grooming, walking, 
sleeping, and epileptic seizures. We observed spontaneous seizures at Wk 10 and several 
sleep/wake cycles at Wk 16. The sleep/awake time we determined from our detailed 
notes during the recording session. The rat dozed off (laid down, eyes closed) 
periodically which we named as a sleep cycle. When the rat started moving around the 
cage or we saw movement with eyes open we named them wake cycle. We did not 
observe any movement artifacts when the rat walked, groomed, or slept. However, 
pronounced motion artifacts occurred whenever the rat bumped its head on the side of the 
cage. The magnitude of this artifact was greater than two times the highest current peaks 
seen during normal behaviors. One example of how GLU and GABA varies with 
behavior can be seen in a segment of the Wk 10 recording (Figure 6-9A).Activities 
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during this recording include walking, resting, grooming, and several different types of 
seizure behaviors. At the start of this segment, the rat was awake but not moving 
(horizontal gray bar on the left). During this 70-s time period, several short and steep 
fluctuations occurred that resemble interictal spikes, commonly observed in 
electroencephalograms, that suggests a seizure has recently occurred or is about to occur 
[117], [118]. The full duration of these spikes (time from departure to return to baseline) 
was 443.3 ± 136.6 ms (mean ± SD, n = 9) and the frequency of these spikes was 0.13 Hz. 
GABA and GLU concentrations were calculated using calibration curves for each 
biosensor that were constructed prior to recording. The concentration at these low points 
was 4 ± 1 µM and 2 ± 0.8 µM for GLU and GABA, respectively and baseline levels were 
18 ± 4 µM and 15 ± 5µM, respectively (mean ± SD, n = 9).The period of interictal-like 
spiking was followed by normal walking with larger and more frequent fluctuations in 
both neurotransmitters. After this we observed lower amplitude fluctuations on the same 
baseline as the rat rested. The frequency of these periods was similar (walking, 9.7 Hz; 
resting, 13.0 Hz). Following these time periods, a rapid increase in fluctuation amplitude 
(GLU, 6 ± 2 µM; GABA, 10 ± 3 µM), and frequency (28 Hz) preceded and continued 
through a 21s long period of grooming. A brief, 3s rest period followed. During this time, 
the GABA baseline began to decrease while the GLU baseline remained unchanged. As 
the rat began grooming again both GLU and GABA baseline concentrations steadily 
dropped from 18 µM to 8 µM for GLU and from 17 µM to 5 µM for GABA (Figure 
6-9A, middle gray bar shows GABA baseline slope). After a steep decrease in GABA 
(Figure 6-9A, left downward arrow), baseline GABA slowly increased but remained 
below baseline by 50%, while baseline GLU remained steady. 
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Figure 6-9: In vivo GLU (black) and GLU (blue) dynamics change with different 
types of behavior.  A. Vertical scale bar 1 nA and horizontal scale bar 20 s for both 
GLU and GABA traces.  B.C. Representative sleep-wake cycles at week 16. Vertical 
scale bars 0.5 nA and 1.0 nA for top and bottom plots, respectively, and horizontal 
scale bars represent 2 min for both. D. Signal after two weeks after cannula 
implantation Vertical scale bar 0.1 nA and horizontal scale bar 125 ms. E. signal from 
the same rat as shown in D, 8 weeks after the first recording. Vertical scale bar 0.2 nA 
and horizontal scale bar 100 ms (Figure provided by P.T. Doughty, K.A. Ponder and 
T.A. Murray, 2020).  
 Several behaviors are captured in this 8-min 40-s recording in Figure 6-9A. Ictal-
like peaks appear in the first 70 s when the rat is not moving (horizontal gray bar). This is 
followed by walking and grooming (between left and middle gray bars). Movement 
ceased between the two downward arrows as the rat abruptly stopped moving (frozen 
posture). A rapid decrease in GLU and GABA occurred at the onset of freezing (left 
arrow). GABA gradually increased until the point when the rat clearly exhibited seizure 
behavior with forelimb clonus, which is a Racine Scale 3 behavior during epileptic 
seizures in rats. Coinciding with clonus are brief sharp peaks in both neurotransmitters 
(right arrow). After this, GABA and GLU fluctuated rapidly and after a few seconds the 
rat began rearing and fell which are Racine Scale 4 and 5 behaviors, respectively. 
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Maximum current fluctuations in both biosensor channels were observed just before and 
through rearing. After this, the rat ceased rearing but continued to exhibit mouth and 
facial movements with some occasional head bobbing for the remainder of this recording 
segment. These are Racine Scale 1 and 2 behaviors, respectively. During this period, 
GABA current dropped rapidly (just before inclined gray bar, A) and then steadily rose 
(slope denoted by inclined gray bar on right, Thirty-three seconds after the sudden drop 
in GABA, the rat had a seizure that began with forelimb clonus (Figure 6-9A, right 
downward arrow) with brief simultaneous peaks in both neurotransmitters (GLU 
increased 50.0 ± 25.0% and GABA 50.0 ± 14/3% over their baseline concentration, 
respectively). Forelimb clonus is a Racine Scale 3 behavior in rodent models of 
epilepsy[119]. Within two seconds, large amplitude and rapid changes in GLU and 
GABA began to occur. A few seconds later, the rat reared and fell over, which are Racine 
Scale 4 and 5 behaviors, respectively. The large peaks in both neurotransmitters ended as 
the seizure behavior transitioned to Racine Scale 1 facial movements. The baseline of 
both neurotransmitters remained below pre-seizure levels with progressively lower 
fluctuations in concentration of around 1 µM for each neurotransmitter. Baseline GLU 
concentration remained at 8 ± 4 µM while GABA slowly rose from 2 to 6µM. Almost 
two min after the seizure began, the GABA signal suddenly decreased again to 2 µM and 
then began a steady increase over the next two minutes to 11 µM (Figure 6-9A, inclined 
gray bar to right). Baseline levels of both neurotransmitters remained lower than pre-
seizure baseline throughout the seizure.  
We compared the mean baseline concentration for each behavior (Figure 6-9 A) 
and calculated an E:I ratio for each. As expected, seizure activity was dominated by 
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excitation. The E: I for interictal activity were 1.20 and for Racine Scale 1 – 5 behaviors 
it was 2.88. Conversely, awake behaviors of walking, resting and grooming were 
dominated by inhibition (E: I = 0.89). During the pre-seizure period (between arrows, 
Fig. 8A) and as seizure was waning, during the last two minutes of the recorded traces, 
the E:I ratio was 1.0. Notably, the mean E: I ratio for the entire period was dominated by 
excitation (E: I = 1.39).  
A very different relationship of GLU and GABA signals was observed during 
sleep cycles. GABA signals rose before the onset of sleep. Prior to arousal, the GABA 
current rapidly declined. Six sleep-wake cycles from week 16 are shown in Figure 6-9B, 
C, with sleep denoted by horizontal gray bars. Mean peak concentration of GABA during 
sleep increased 31.2±8.6% (mean±SD, n = 6) above the overall mean for the series of 
sleep-wake cycles and then decreased 31.9±11.7% (mean±SD, n = 6) during awake 
behaviors. Whereas relatively large changes were observed in GABA, the concentration 
of GLU remained stable throughout these cycles, although it did rise and fall during other 
types of behaviors (not shown). The maximum GABA concentration during periods of 
sleep and the minimum concentration for periods of wakefulness were used to calculate 
the E: I ratio for each episode. The mean E: I ratios for sleep and wakefulness were 0.67 
± 0.04 and 1.32 ± 0.24, respectively (mean ± SD, n=6 each) indicating that inhibition 
dominated during sleep and excitation during wakefulness. Interestingly, the mean E: I 
for all sleep and wake periods were 0.995, which is close to complete balance. GABA 
current steadily increased prior to each of six episodes of sleep (gray bars) and remained 
elevated with some fluctuation during sleep. Immediately prior to waking, GABA levels 
rapidly fell and remained low during activity. 
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Biosensor current was recorded at 1000 Hz for all sessions. Recordings were 
generally down-sampled and smoothed to better observe shifts in neurotransmitter levels 
with behavior. When analyzing raw current data, subsecond fluctuations in GABA and 
GLU current were observed that were not related to electronic noise (e.g., not 60 Hz 
oscillation). Two examples are shown in Figure 6-9(Panels D & E); both recordings were 
acquired during calm walking. As glutamatergic and GABAergic neurons form feedback 
networks in the hippocampus, it was not surprising to observe some opposing transient 
changes in current. The first example illustrates this phenomenon with a decrease in 
GABA and corresponding increase in GLU (asterisk, Figure 6-9 D). This set of peaks had 
a FDHM of 70 ms. Peak current was determined using calibration curves for each 
biosensor channel. Mean GABA concentration before and after the peak was 3.8 µM and 
5.1 µM, respectively. Concentration rapidly decreased by 0.6 µM then increased by 1.8 
µM and remained slightly higher. GLU followed a similar time course, but the signal was 
inverted compared to GABA. Mean GLU concentrations before and after this peak 
were15.3µM and 12.1µM, respectively. Peak concentration increased by 1µM and then 
rapidly declined by 4 µM and remained low during this time segment. 
The second example of sub-second fluctuations in GABA and GLU current were 
recorded eight weeks later in week 10 (Figure 6-9). In contrast to the simultaneous, 
opposing peaks in Figure 6-9 D, the two peaks in Figure 6-9 E was separated by 600ms. 
Mean GABA concentration before and after the drop (asterisk) was 19 µM and 22 µM, 
respectively. GABA rapidly dropped by 8 µM and then increased by 11 µM. Mean GLU 
concentration before and after the peak (asterisk) was 15 µM and 14 µM, respectively. 
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GLU increased by 4 µM and decreased by 5 µM. The GABA and GLU peaks had a 
FDHM of 235 ms and 128 ms, respectively. 
6.2.6 Peak Concentration Depends on Stimulation Frequency 
While extracellular GABA and GLU peak concentration increased with 
increasing stimulation frequency, their responses were different. Mean peak GABA 
concentration increased 26-fold over baseline compared to 15-fold increase for GLU. In 
addition, we observed a linear increase in hippocampal GABA release with increasing 
stimulation frequency. In contrast, GLU increased at a lower rate from 50 Hz to 140Hz 
stimulation versus from 10 Hz to 50Hz. It appears that the glutamatergic neurons in CA1 
are less sensitive to 140Hz stimulation. Our results are in agreement with Mantovani 
et.al., who reported a marked increase in GABA release and little effect on GLU release 
in human neocortical brain slices after 130 Hz stimulation [120]. Using optogenetics, 
Chiang et.al.,also found that high frequency stimulation of the hippocampus 
predominantly drove GABA release [113]. GABA release is primarily achieved through 
activation of GABA receptors. For example, the GABA release during the high frequency 
stimulation of human neocortical slices was dependent on GABAA receptor-mediated 
chloride influx [120], [121]. However, GABA release was also dependent on voltage-
gated sodium channels. This combined effect of Cl- and Na+ dependent release of GABA 
may have contributed to the relatively high concentration of GABA with 140 Hz 
stimulation. 
Other research on the effects of electrical stimulation[122] and optogenetic 
stimulation [123]  have revealed frequency-dependent increases in extracellular GLU in 
the sub-thalamic nucleus and globus-pallidus, respectively, likely due to increased 
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neuronal stimulation and/or decreased astrocytic uptake. Similarly, we expected that the 
glutamate responses in the hippocampus would vary with stimulus frequency. Another 
study observed a linear increase in thalamic GLU release (up to 400 µM) with 
stimulation frequency from10 Hz to 300 Hz [124]. The authors identified two sources of 
GLU release, one from depolarization of glutamatergic afferents to the thalamus, a 
neuronal source, and release of stored vesicular GLU in astrocytes, a non-neuronal 
source. They also noted that because astrocytes are non-excitable cells, they are more 
likely to produce linear response to electrical stimulation. Our data shows a non-linear 
increase in hippocampal GLU release (up to 264 ± 43 µM) with stimulation frequency 
(10 – 140 Hz). This increase could be due to increased recruitment and depolarization of 
glutamatergic neurons [114], and possibly electrically stimulated release of stored GLU 
from astrocytes [112]. 
Peak GABA concentrations in our study were much higher than commonly 
reported concentrations in the hippocampus using microdialysis. Those studies reported 
basal levels up to 0.5 µM for GABA [125], [126] and, after KCl stimulation, levels 
increased up to 2.5 µM for GABA [126]. In contrast, at least one microdialysis study 
reported a nearly 1000% higher concentration after stimulation with KCl [127], which is 
far lower than our maximum peak concentration. In the present study, we stimulated the 
Schaffer collaterals, which is likely to elicit synchronous firing in CA1 that recruits a 
relatively large number of glutamatergic pyramidal cells and GABAergic interneurons 
[96]. Given the placement of our microwires, a large proportion of our biosensor surfaces 
were probably in close contact with active synapses of these cells [27], not only during 
the response to electrical stimulation but also between stimulation as these neurons are 
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known to fire tonically[128]. Thus, we would expect to detect higher baseline and peak 
concentrations of GABA after electrical stimulation. Similar to our observations, another 
research group has shown that synaptically released GABA in cultured rat primary 
hippocampal cells reach transiently high concentrations (∼1.5−3 mM) using 
electrophysiology and computer modeling [129].Similar to GABA, the baseline and peak 
GLU concentration that we observed was higher than microdialysis studies. However, 
our range of concentrations was similar to the range of concentrations found in other 
studies [27]. 
6.2.7 E: I Ratio Varies Nonlinearly with Stimulation Frequency 
We observed a marked decrease in the E: I ratio in CA1 from 10 Hz to 50Hz 
stimulation and from 10 Hz to 140Hz pulses. This decrease was nonlinear. There was 
also a nonsignificant trend suggesting a possible decrease from 50 Hz to 140Hz. For the 
low frequency, 10Hz stimulation, the E: I ratio was greater than one suggesting that 10Hz 
pulses elicit an overall excitatory response in CA1. In contrast, the 50 Hz and 140Hz 
stimulations resulted in E: I ratios of less than one. Even though both GLU and GABA 
concentrations increased with 50 Hz and 140Hz pulses, the balance shifted to an 
inhibitory response with markedly higher GABA concentrations, especially after 140Hz 
stimulation. Increased GABA inhibition likely led to the nonlinear increase in GLU. To 
avoid GLU excitotoxicity, the absolute concentration of GLU may not be as important as 
the ratio of excitatory to inhibitory signaling. A human and nonhuman primate study has 








CONCLUSION AND FUTURE WORK 
 
7.1 Conclusion 
In this dissertation we have developed a detailed understanding of GLU-GABA 
probe based on our novel mechanism. We characterized and validated our probe in both 
commercial and wire-based platform. We were able to show the effects of process 
parameters in sensor performance. We were able to demonstrate the application of these 
sensors in brain tissue slices and freely awake moving rats. The following conclusions 
can be drawn from our work on sensor development in ceramic based 8-TRK probes. 
1. To determine GABA and GLU our sensor does not require addition of 
external reagents (e.g., α-ketoglutarate). In that sense our sensor is truly is 
truly self-sufficient and is the first of its’ kind. 
2. GABA sensitivity is highest when we have 0.1unit/μL GABASE and     
0.1unit/μLGOx. The sensitivity value is 141 nA/μMcm2 which is almost 4 
times the value found in literature [14], [15]. However, the GLU 
sensitivity is highest when we have 0.4unit/μLGOx. The sensitivity value 
is 335 nA/μMcm2 which is comparable to previous work done in our lab 
[90]. 
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3. Both GABA and GLU sensitivity is highest when have one drop of 
enzyme (optimum enzyme loading). The thickness in that was 0.49±0.03 
for GABA electrode and 0.38±0.05 in case of GLU electrode. The 
thickness increased with higher loading and sensitivity decreased. 
4. The enzyme activities and sensor performance are pH dependent. GABA 
electrode gives highest GABA sensitivity at pH=9 and GLU sensitivity is 
highest at pH=7. This information helps us to interpolate various pH 
conditions in our experimental environment. 
5. The GABA electrode follows the Michaelis-Menten equation. The 
saturation concentration depends upon the amount of α-ketoglutarate in 
the solution. The saturation limit is ~100 μM GABA (sensitivity is lower 
for low α-ketoglutarate concentration). 
6. A layer of meta-polyphenylene diamine acted as our interference rejection 
layer. It blocks all the common interferent that is found in normal brain 
environment. Additionally, we demonstrated that this layer can be 
customized for thickness by varying the scan rate.   
7. We were able to validate our sensor in brain slice environment and use our 
novel procedure for quantification of GABA and GLU. 
In our wire-based sensor characterization we took the optimum parameters of 
sensor design and solved the dimensional issue we faced in the 8-TRK probe. We were 
also able to validate our custom probe ex-vivo and in-vivo. The following conclusions can 
be drawn from wire-based sensor experiments. 
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1. Our microwire biosensor design is not only advantageous for future, 
longitudinal in vivo recording, its geometry has distinct advantages over 
shank-style neural recording probes for brain slice and cell culture models. 
Shank-style probes are designed to record electrical signals from different 
regions of the brain for in vivo studies. In contrast, brain slices are cut thin 
and placed horizontally in a recording chamber to extend tissue viability 
and function. Thus, a geometric profile in which all of the microwire 
biosensor sites contact the slice in the same horizontal plane provides an 
advantage. Similarly, cultured cells for in vitro models grow in a thin layer 
on a flat cell culture dish. Again, a microwire biosensor in which all probe 
sites are in a horizontal plane equidistant from the cells is a desirable 
arrangement. In our previous studies, we experienced difficulties in using 
shank-style microbiosensor arrays when recording from brain slices and 
cultured cells. When recording in brain slices, we could only use two of 
the eight sensor sites on a shank-style probe; the same was true for cell 
culture recording. 
2. The sensitivity of GABA channel is 17 ±1.12 nA/μMcm2. We note that 
GABA sensitivity is dependent upon the storage conditions. If the sensors 
are stored 4°C instead of room temperature, we get almost 10-times more 
sensitivity. 
3. The GLU sensitivity is 95±9.34 nA/μMcm2 which comparable to sensors 
in similar geometry[131]. 
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4. The GLU linear range is 0-300 μM and GABA linear range is 0-500 μM, 
which makes our packaging suitable for high concentration recording. 
5. We validated our probe in the tissue environment with varying 
frequencies. We were able to measure GLU and GABA levels real-time 
continuously. We were also able to measure E: I ratio for different 
frequencies. Interestingly, we observed a huge activation of GABAergic 
neurons at 140 Hz. This excess GABA could have reduced excitatory 
synaptic transmission by decreasing excitatory postsynaptic potentials and 
GLU release and even block action potential propagation as suggested by 
Ruiz et al. We observed progressively smaller peak concentrations of 
GABA and GLU as stimulation frequency decreased [115]. However, the 
E/I ratio was not linear, suggesting that GABA and GLU release in 
response to different frequencies of stimulation is complex. Our system 
should be useful in studying responses to a wide range of stimulation 
parameters. 
6. We measured GLU and GABA levels in awake-freely moving live rat. We 
were able to track sub-second concentration fluctuation of both GABA 
and GLU. 
7.2 Future Work 
Our works lays out a structured framework for GABA and GLU microelectrode 
sensor. Based on our research experience obtained in my dissertation, I would like 
suggest the following future work guidelines: 
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1. Electrochemical deposition of the enzyme in the electrode surface. This 
has been demonstrated before in literature[132]–[134]. Our preliminary 
data is shown in Figure 7-1 In this experiment 10 Vp-p is used for 15 
minutes. 
 
Figure 7-1: A.GLU calibration 1-100 µM for different frequency. The sentinel used 
here is coated with BSA at 1000 Hz (red line). The sensitivity at 30 Hz is 282±38 
nA/μMcm2, the sensitivity at 100 Hz is 522±68 nA/μMcm2, the sensitivity at 250 Hz 
is 624±72 nA/μMcm2, the sensitivity at 750 Hz is 384±56 nA/μMcm2and the 
sensitivity at 1000 Hz is 320±43 nA/μMcm2. 
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2. Addition of microfluidic channel for in-situ calibration. In our experiments 
we use the calibration values before the ex-vivo/in-vivo experiments to 
calculate the peaks (concentration). However, if the electrode fouls during 
the course of the experiments we have no way to account for that. A 
micro-fluidic channel along the channels (shank) will enable us to inject 
constant amount of our analyte and check for sensitivity instantaneously. 
3. Addition of one wire for ascorbic acid measurement. We can keep better 
track of our interferent (distinguish between H2O2 and ascorbic acid) if we 
coat one wire with ascorbate oxidase and interferent layer. This fourth 
wire can help measure H2O2 and other ROS, whereas other channels are 





APPENDIX A  
 
LINEAR RANGE AND MICHAELIS-MENTEN EQUATION 
 
A.1 Saturation Kinetics and Michaelis-Menten Equation 
For most of the chemical reactions, the reaction rate is proportional to the 
concentration of the reactant. So, these chemical reactions follow straight-line formula. 
However, enzyme-catalyzed reactions do not follow this paradigm. Typically if we  plot 
the initial velocity of an enzyme as function of substrate concentration we get a  
rectangular hyperbola [135] as shown in Figure A-1. 
 
Figure A-1: The rate, or velocity, of an enzyme-catalyzed reaction as a function of 
substrate concentration 
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The contemporary Michaelis-Menten equation relates these parameters: Vmax and 
KM. The KM is the substrate concentration at half-maximal velocity, which corresponds to 




 Eq. A-1 
Here v represents the reaction velocity, vmax is the maximal velocity, KM the 
substrate concentration at half-maximal velocity, and[S] is the substrate concentration. 
We can conclude from here that, in normal conditions and specific amounts of enzyme, 
an enzyme exhibits a maximum velocity (Vmax), which is approached as a limiting value 
as the substrate concentration increases. The half of Vmax and the corresponding 
concentration, KM defines the linear range of enzymatic oxidation. This linear range is 
very important in our sensor development. Throughout our studies we have shown the 
linear range for our sensors (both 8-TRK and wire based).  
A.2 Linear Approximation and Enzyme Inhibitory Mechanism 
We rewrite Eq. A-1 to get the linear equation for the reaction velocity, v. This 










 Eq. A-2 
This equation can be compared with the equation for a straight line: y=mx+b, 
where m is the slope and b is the y-intercept. In the Lineweaver-Burk equation, KM/Vmax 
is the slope (or m) and 1/Vmax is the y-intercept (or b). For enzymes that obey Michaelis-
Menten kinetics, when the reciprocal of the substrate concentration (1/S) is plotted versus 
the reciprocal of the velocity (1/v), results similar to those displayed in Figure A-2 is 
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obtained.  Lineweaver-Burk equation can be used to explain multi-substrate and multi-
enzyme reaction kinetics. 
 
Figure A-2: Lineweaver-Burk equation for enzyme dependent oxidation 
For enzymes with subsequent reaction, the vmax value and the slope value can shift 
upward or downward based on the type of reaction. This has been also used to explain 
multi-substrate reaction[136]. We also note that, the slope in this case is the reciprocal of 
the sensitivity. The increased slope value gives us lower sensitivity.  
In the traditional approach, reversible enzyme inhibitors bind nearly 
instantaneously to the active sites of enzymes to exert their inhibitory effect[135]. There 
are three different types inhibitory mechanisms available [135]. In the competitive 
mechanism, inhibition occurs because enzymes bind to the same substrate as inhibitor; 
therefore, the slopes increases which results in the loss of sensitivity [135]. In 
uncompetitive mechanism, inhibitor binds to the enzyme-substrate complex and slopes 
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remains constant. In this mechanism no significant change in sensitivity is observed 
[135]. In non-competitive mechanism, the inhibitors bind to both free enzymes and 
enzyme-substrate complex. In this case, both the slope and x-intercept can change in both 
directions depending on reaction conditions. Therefore, we expect change in both 
sensitivity and linear range. The predominant mechanism in our experiments is assumed 
to be the competitive inhibition mechanism. In our case, when GABASE concentration 
increases, the sensitivity decreases. The same is true for GOx enzymes. We can 




APPENDIX B  
 
GABA AND GLUTAMATE SENTIVITY COMPARISON 
 
Table B-1 shows the GABA and GLU for different enzyme concentration 
described in 4.3. 
Table B-1: Sensitivity of GABA and GLU enzyme in varying enzyme concentrations. 
GABAse+GOx is the enzyme concentration. SSGABA and SSGABA-GLU is GABA and 
GLU sensitivity of GABA electrode. SSGLU is GLU sensitivity of GLU electrode 
GABAse+GOx SSGABA SSGABA-GLU SSGLU 
0.05+0.1  68±7  112±11  102±10  
0.05+0.2  56±5  147±14  127±11  
0.05+0.3  54±5  183±9  163±13  
0.05+0.4  51±4  213±15  198±18  
0.05+0.6  51±4  90±6  85±8  
0.05+0.8  49±3  81±7  74±6  
0.1+0.1  82±11  201±20  167±15  
0.1+0.2  65±9  258±22  199±17  




Table B-1 (cont.): Sensitivity of GABA and GLU enzyme in varying enzyme 
concentrations. GABAse+GOx is the enzyme concentration. SSGABA and SSGABA-GLU 
is GABA and GLU sensitivity of GABA electrode. SSGLU is GLU sensitivity of GLU 
electrode. 
GABAse+GOx SSGABA SSGABA-GLU SSGLU 
0.1+0.4              44±8 397±32  335±29  
0.1+0.6              36±7 228±12  200±11  
0.1+0.8             32±14 210±11  180±8  
0.2+0.1 72±10 151±15  138±18  
0.2+0.2 63±7 195±19  187±17  
0.2+0.3 62±8 245±23  221±19  
0.2+0.4 59±7 299±27  268±24  
0.2+0.6  61±6 132±13  119±11  
0.2+0.8  59±4 113±9  101±9  
0.3+0.1 53±5 98±9  87±5  
0.3+0.2 45±4 130±12  121±13  
0.3+0.3 44±4 151±14  145±16  
0.3+0.4 43±3 181±15  168±20  
0.3+0.6  42±4 87±9  76±9  
0.3+0.8  43±3 75±5  68±7  
0.4+0.1 39±4 148±11  129±18  
0.4+0.2 31±3 187±15  173±17  




Table B-1 (cont.): Sensitivity of GABA and GLU enzyme in varying enzyme 
concentrations. GABAse+GOx is the enzyme concentration. SSGABA and SSGABA-GLU 
is GABA and GLU sensitivity of GABA electrode. SSGLU is GLU sensitivity of GLU 
electrode. 
GABAse+GOx SSGABA SSGABA-GLU SSGLU 
0.4+0.4 30±4 286±23  256±24  
0.4+0.6  28±5 127±11  106±11  
0.4+0.8  30±7 107±10  95±9  
0.8+0.1  17±4 89±8  82±5  
0.8+0.2  14±3 123±10  114±11  
0.8+0.3  13±3 145±13  133±18  
0.8+0.4  14±2 167±18  153±19  
0.8+0.6  13±1 79±8  68±6  






APPENDIX C  
 
WILCOXON RANK SUM FOR DIFFERENT PARAMETERS 
 
C.1 GLU and GABA Concentration 
Table C-1: Wilcoxon rank for GLU concentrations A, B, C and control (Ctrl) pulse 
 A B C Ctrl 
A 0 0.0392 0.0546 0.0809 
B 0.0392 0 0.0626 0.0469 
C 0.0546 0.0546 0 0.0045 
Ctrl 0.0809 0.0469 0.0045 0 
 
Table C-2: Wilcoxon rank for GABA concentrations A, B, C and control (Ctrl) pulse 
 A B C Ctrl 
A 0 0.014 3.2 x10-5 0.441 
B 0.014 0 0.09 9.1 x10-5 
C 3.2 x10-5 0.09 0 2.9 x10-12 




C.2 Wilcoxon Rank for GLU Peak Characteristics 
Table C-3 shows the wilcoxon rank for GLU rise time (T10-90) for A, B, C and 
control (ctrl) pulse. 
Table C-3: Wilcoxon rank for GLU rise time (T10-90) for A, B, C and control (Ctrl) 
pulse. 
 A B C Ctrl 
A 0 0.014 4.89 x10-5 0.08 
B 0.014 0 0.030 0.17 
C 4.89 x10-5 0.030 0 2.03 x10-5 
Ctrl 0.08 0.17 2.03 x10-5 0 
 
 Table C-4 shows wilcoxon rank for GLU decay time (T90-10) for A, B, C and 
control (Ctrl) pulse. 
Table C-4: Wilcoxon rank for GLU decay time (T90-10) for A, B, C and control (Ctrl) 
pulse. 
 A B C Ctrl 
A 0 0.047 1.02 x10-5 0.40 
B 0.047 0 9.8 x10-4 0.003 
C 1.02 x10-5 9.8 x10-4 0 4.97 x10-20 
Ctrl 0.40 0.003 4.97 x10-20 0 
 
Table C-5 shows Wilcoxon rank for GLU FDHM (T50-50) for A, B, C and control 
(Ctrl) pulse. 
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Table C-5: Wilcoxon rank for GLU full duration half maximum (T50-50) for A, B, C and 
control (Ctrl) pulse. 
 A B C Ctrl 
A 0 0.0016 5.12 x10-7 1.09 x10-6 
B 0.0016 0 1.15 x10-7 0.5103 
C 5.12 x10-7 1.15 x10-7 0 1.01 x10-7 
Ctrl 1.09 x10-6 0.5103 1.01 x10-7 0 
 
C.3 Wilcoxon Rank for GABA Peak Characteristics 
Table C-6 shows the wilcoxon rank for GABA rise time for A, B, C and control 
(Ctrl) pulse. 
Table C-6: Wilcoxon rank for GABA rise time (T10-90) for A, B, C and control (Ctrl) 
pulse. 
 A B C Ctrl 
A 0 2.03 x10-4 3.03 x10-9 0.01 
B 2.03 x10-4 0 0.01 0.02 
C 3.03 x10-9 0.01 0 5.01 x10-9 
Ctrl 0.01 0.02 5.01 x10-9 0 
 
Table C-7 shows wilcoxon rank for GABA decay time (T90-10) for A, B, C and 
control (Ctrl) pulse. 
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Table C-7: Wilcoxon rank for GABA decay time (T90-10) for A, B, C and control (Ctrl) 
pulse. 
 A B C Ctrl 
A 0 0.047 1.2x10-5 0.31 
B 0.047 0 1.09 x10-3 0.003 
C 1.2x10-5 1.09 x10-3 0 4.09 x10-15 
Ctrl 0.31 0.003 4.09 x10-15 0 
 
Table C-8 shows wilcoxon rank for GABA FDHM (T50-50) for A, B, C and control 
(Ctrl) pulse. 
Table C-8: Wilcoxon rank for GABA full duration half maximum (T50-50) for A, B, C 
and control (Ctrl) pulse. 
 A B C Ctrl 
A 0 0.048 9 x10-8 0.30 
B 0.048 0 0.003 0.06 
C 9 x10-8 0.003 0 1.2 x10-10 







C.4 Wilcoxon Rank for E: I Ratio 
Table C-9 shows the wilcoxon rank for E: I ratio for A, B, C and control (Ctrl) 
pulse (Figure 6-8). 
Table C-9: Wilcoxon rank for E: I ratio for A, B, C and control (Ctrl) pulse. 
 A B C Ctrl 
A 0 0.0482 0.002 0.0122 
B 0.0482 0 0.0916 0.5098 
C 0.002 0.0916 0 0.6377 
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